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PREFACE:
My dissertation research at the University of Memphis investigated the effects of
environmental factors on sensitivity of bacteria to antibiotics. I used Azotobacter
vinelandii as model organism to optimize the environmental factors for enhancing
antibiotic efficacy. Here, I present one chapter as a general introduction about current
proposed mechanism of antibiotic action; the associated problems and debates on the
proposed model; and different approaches to address the global health issues on
antimicrobial resistance. One chapter is a comprehensive literature review on
environmental pollutant Triclosan, two chapters directly address my dissertation research
goals, and one chapter is the final conclusion of my dissertation research.
Chapter 2, titled “Enhancing antibiotic efficacy through factorial design”, is formatted
and planned for submission to the journal Journal of Food and Drug Analysis. Chapter 3,
titled “ Triclosan: antimicrobial mechanisms, antibiotics interactions, clinical
applications, and human health” has been published in the journal Journal of
Environmental Science and Health, Part C (Shrestha et al, 2020) and is formatted as such.
Chapter 4, titled “Synergistic and Antagonistic interaction of Triclosan with various
antibiotics in bacteria” has been published in the journal Journal of Environmental
Science and Health, Part C (Shrestha et al 2020) and is formatted as such. This Preface,
Chapter 1: Introduction, and Chapter 5: Conclusion are formatted in the style of Journal
of Food and Drug Analysis. Supplementary materials are available in Appendix I and II.
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ABSTRACT:
Shrestha, P. Ph.D. The University of Memphis. April 2021. Triangulating the
webs of environment influences, bacteria, and antibiotics. Major Professor: Tit-Yee
Wong. Ph.D.
The importance of maintaining a healthy microbiome is being recognized
increasingly. Our research in the gut microbiome and environmental pollutants suggests
that pollutants like particulate matter (PM2.5) and nanometals can induce Reactive
Oxygen Species (ROS) and decrease the microbiome stability. Additionally, the abusive
use of antibiotics in the past has led to great changes in the microbiome and caused the
rise of many antibiotic-resistant strains.
Developing a new antibiotic is costly and time-consuming. Methods to improve
the existing drugs should be cost-effective. A narrow-spectrum antibiotic that targets only
the problematic pathogens should prevent microbiome disruption and reduce the rise of
antibiotic resistance. This requires understanding the physiology of microbes growing in
their specific environment. However, little is known on how environment affect the
bacteria’s response to the antibiotics.
I initiated a project to understand the triangulation between bacteria, their growth
environments, and their responses to different classes of antibiotics. I noticed that
triclosan (TCS), a xenobiotic found in many household products, can often interfere with
an antibiotic. I used 16 different bacterial strains and 6 different classes of antibiotics to
study the interaction between TCS-antibiotic on a bacterium. TCS could act
synergistically or antagonistically with antibiotics. Studies on the antagonistic interaction
suggest that TCS can induce a multidrug efflux pump making the bacteria more resistant
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to certain antibiotics. This discovery also explains a long mystery of the so-called
“paradoxical effect” (also called the Eagle’s Effect) where some strains of bacteria which
could not survive low concentrations of antibiotics would survive at higher
concentrations.
Using Azotobacter vinelandii, a nitrogen-fixing, obligate aerobic bacteria as a
model organism, I demonstrated that interaction of other environmental factors could
change the sensitivity/resistance to a certain antibiotic. The complex interactions between
antibiotic-environmental factors can be partially resolved by using a full-factorial design.
We also proved that oxidative stress as a common mechanism of bacterial cell death
theory does not hold for all antibiotics. Our proof-of-concept model suggests that it is
possible to enhance the efficacy of preexisting antibiotic by manipulating various
environmental factors. This should provide a cost-effective approach towards
personalized medicine as well.
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Chapter 1: Introduction
Antibiotics and antibiotic resistance:
The discovery of the iconic antibiotic Penicillin in 1928 by Alexander Fleming
was celebrated by the world. Since then, various antibiotics were used as miracle drugs
throughout the 20th century that made bacterial infections a curable condition.
Unfortunately, antibiotics are being increasingly used, not only for treating human
diseases but also for increasing the output of animals and aqua farming. The release of
antibiotics into the environment has not been properly regulated by the governments. The
presence of antibiotics in soils and waters has negatively affected human health.
The mechanisms of antibiotics killing microorganisms are complex. The same
antibiotic can be bacteriostatic or bactericidal depending on concentrations or the damage
done by it. Antibiotics can be classified by their targets of different parts of the bacteria.
There are four major targets (Walsh, 2003):
a)

Inhibit DNA/RNA replication and its repair like fluoroquinolones.

b)

Damage cell wall and inhibit cell wall synthesis like penicillin.

c)

Inhibit protein synthesis – targeting the 30S (tetracycline family and

aminocyclitol family) or 50S (macrolide family and chloramphenicol) of the ribosome
subunits; and
d)

Inhibit biosynthetic pathways (like mycolic acid synthesis by isoniazid and folic

acid synthesis by trimethoprim).
Since the rise of antibiotics, there has been a simultaneous rise in resistance
against them. So far, resistance against all known antibiotics has been seen and the
prevalence of drug-resistant bacteria is increasing every day. The evolution of resistance
1

against antibiotics does not take a long time as seen in table 1. The four fundamental
mechanisms of antimicrobial resistance are (1) enzymatic degradation of antibacterial
drugs, (2) modification of bacterial target proteins, (3) changes in membrane permeability
to antibiotics and (4) overexpression of efflux pumps that expel drugs out of the cell. It is
very important to recognize that antibiotic resistance/susceptibility is a relative
phenomenon as it is based on in-vitro experiments with the defined size of bacteria and
other parameters (e.g., pH, nutrients, temperature, the proportion of antimicrobials, etc.).
Many human practices are responsible for the emergence of resistant bacteria:
according to CDC, 50% of antibiotics are still prescribed unnecessarily in the US (CDC,
2013) and lack of public knowledge leads to overuse of antibiotics and abuse of the drugs
in meat production (Landers et al., 2012). The gene that supplies resistance in the bacteria
can transfer from one bacterium to another through a process called horizontal gene
transfer which can create Multi-Drug Resistant Bacteria (MDR). Currently, carbapenem
is used as the last resort drug to kill MDR bacteria like MRSA (Methicillin-Resistant
Staphylococcus aureus). However, side by side bacteria is emerging with new ways to
gain resistance against this antibiotic as well. WHO has published a list of 12 families of
antibiotic-resistant bacteria for which there is an urgent need for new antibiotics
(Govindaraj Vaithinathan & Vanitha, 2018).
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Table 1. Development of antibiotics and evolution of antibiotic resistance (Palumbi,
2001).
Antibiotics
Developed year
Resistance appeared
Penicillin
1943
1946
Streptomycin
1943
1959
Chloramphenicol
1947
1959
Tetracycline
1948
1953
Erythromycin
1952
1988
Vancomycin
1956
1988
Methicillin
1960
1961
Ampicillin
1961
1973
Cephalosporins
1960s
late 1960s

The presence of drug efflux systems often allows bacteria to resist multiple
antibiotics. Many drug efflux systems are substrate non-specific. Efflux pumps are
transporter proteins. They can be classified into five families based on their primary
structure and energy-coupling mechanism:
i. Major Facilitator Superfamily – MFS,
ii. Adenosine Triphosphate-Binding Cassette – ABC,
iii. Small Multidrug Resistance Family – SMR,
iv. Resistance-Nodulation-Cell Division Superfamily – RND, and
v. Multidrug and Toxic Compound Extrusion Family – MATE (Kumar &
Schweizer, 2005). These proteins were firstly described in Escherichia coli associated
with tetracycline resistance profile (McMurry et al., 1980).
Approaches to address microbial drug resistance:
The threat of antimicrobial resistance has become more immediate than ever
before. In 2017 WHO published a list of priority pathogens list which contains 12 classes
of bacteria that are resistant to most existing treatments and therefore, pose an increasing
risk to human health. We are in immediate need of drugs that can kill multi-drug-resistant
3

bacteria. However, the discovery rate of new antibiotics is slowing such that the number
of withdrawals of antibiotics from healthcare exceeds the number of approvals by a factor
of two (Kinch et al., 2014). According to the report published by WHO in 2017, there are
51 antibiotics and biologicals in the clinical development phase of which only eight are
truly innovative and at most two are effective against the Gram-negative pathogens. Even
then, it takes 10 years for them to reach the market because new antibiotics must undergo
many clinical trials and regulatory hurdles before making it to the market. As such,
improving the efficacy of the current antibiotics is a better solution because it saves time,
effort, and money.
Different approaches have been used to address the issue of global antimicrobialresistant threats. One of such strategies is modifications of existing antibiotics that will
have either regained potency against the resistant microbes or extended their spectrum
against the bacteria. For example, among the β -lactam antibiotics up to four generations
of cephalosporins have been developed with multiple modifications of penicillin.
However, this strategy is failing as bacteria develop resistance against such modified
antibiotics quickly. The structural similarity of the drugs and the continued pressure
against the same enzyme that gives the resistance may be the cause of rapid drug
resistance.
The other strategy is using combination therapy where two or more drugs are used
to treat the infection. Although there are few instances of benefits of using combination
therapy, combination therapy being better than monotherapy is still controversial.
Combination therapy increases the cost, adverse effects on human health, and
unpredicted interaction between the drugs. Most of the studies have found that
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combination therapy does not give benefit when compared to monotherapy (Lode, 2007;
Rahal, 2006; Safdar et al., 2004). Further, antibiotics acting synergistically may not be
the required solution. Recent in vitro studies suggest that synergistic antibiotic
combinations may speed up the rate of resistance evolution (Hegreness et al., 2008; PenaMiller et al., 2013). To better cope with this problem, we must understand the
multilayered mechanism of how antibiotics kill bacteria. Our basic understanding of how
antibiotics work is through drug-target interaction affecting cellular systems. However,
our understanding of the bacterial responses that occur because of the primary drug-target
interaction is still incomplete. Filling this gap could give valuable insight towards
improving the efficacy of antibiotics.
A unifying mechanism proposed for the mode of action of antibiotics:
Collins and his group in 2007 proposed a common mechanism for bacterial killing
by antibiotics. According to them, bactericidal antibiotics induce oxidative stress via the
production of Reactive Oxygen Species (ROS) which kills the bacteria (Belenky et al.,
2015; Dwyer et al., 2014; Kohanski et al., 2007; Lobritz et al., 2015). They claim that all
bactericidal antibiotics induce ROS molecules as a secondary response to drug-target
interaction. Thus, developed oxidative stress is the final course of bacteria-killing.
Free radicals and oxidative stress
A free radical is a molecule with one or more unpaired electrons in its outer shell.
Most free radicals are made up of oxygen or nitrogen. Living cells, including bacteria,
can produce many different ROS by-products, such as superoxide anion radicals,
hydrogen peroxide (H2O2), and hydroxyl radicals (•HO) as normal metabolic byproducts
through the Haber-Weiss process:
5

Fe3+ + •O2 → Fe2+ + O2;
The reaction is followed by the Fenton reaction:
Fe2+ + H2O2 → Fe3+ + OH− + •OH
Fe3+ + H2O2 → Fe2+ + HOO• + H+
Nitric oxide (NO) is generated during the breakdown of arginine to citrulline by the nitric
oxide synthase:
C6H14N4O2 + O2 → C6H13N3O3 + NO
NO reacts with superoxide forming proximitized,
O2- + NO → OONO–
Free radicals are involved in a wide range of biochemical processes such as
isomerization, reduction, and rearrangement reactions. Free radicals are not stable. They
are rapidly engaged in other secondary reactions by binding to DNA, proteins, lipids, and
other biomolecules. Common free radicals are hydroxyl radical, superoxide anion radical,
hydrogen peroxide, oxygen singlet, hypochlorite, nitric oxide radical, and proximitized
radical. When binding to unsaturated lipids, free radicals can induce lipid peroxidation.
Lipid peroxidation is a chain reaction (Propagation). The terminal products of lipid
peroxidation are more reactive aldehydes, lipid radicals, and other reactive products.
Unstopped lipid peroxidation could not only damage a single cell, but free radical
propagation will also affect the cells at the propagation site. End-products of lipid
peroxidation, such as malondialdehyde, are also toxic to many cells, including bacteria
(Ni et al., 1996).
ROS may be generated by energy- or electron-transfer reactions. The electron
transport chain is a common site where ROS is produced (Xiong et al., 2014). The
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obligate anaerobes such as Bacteroides fragilis would generate many ROS during the
conversion of succinate to fumarate in its TCA cycle (Meehan & Malamy, 2012). One of
the functions of the electron transport chain is to prevent excess ROS formation by
slowing down the electron flow(Slonczewski & Foster, 2016).
Cells always try to keep balance in oxidative stress.
A cell always tries to keep balance in its oxidative stress. Failure to balance the
oxidative stress can kill the bacterial cell. In response to different conditions that increase
the level of free radicals in a bacterial cell, bacteria produce anti-oxidative enzymes to
keep the balance. Most bacteria are equipped with various protective enzymes, such as
superoxide dismutase, peroxidase, and catalase to detoxify free-radicals and prevent the
cells from oxidative damage. These antioxidative enzymes neutralize different types of
free radicals and support balance in oxidative stress inside the cell. For example, catalase
decomposes hydrogen peroxide to water and oxygen, superoxide dismutase converts
superoxide radicle into molecular oxygen and hydrogen peroxide.
Oxidative stress causes dysbiosis of the gut microbiome:
Overuse of antibiotics and their improper regulation causes their release into the
environment. They can mix with environmental pollutants, like smog, and enter the
human body causing microbiome dysbiosis (Kraemer et al., 2019). Similarly, other
elements of the pollutants and smog can interfere with our gut microbiome. For example,
transition metals in smog can penetrate the cell membrane and uncouple the normally
regulated electron transfer. The uncontrolled transfer of electrons could increase ROS
formation and induce oxidative stress of the bacterium.
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Bacteria in a gut community would interact with each other either positively or
negatively. Positive interactions include the sharing of components of the preferred
environment, which may also help a third-party indirectly as discussed above. The “Black
Queen Hypothesis” (Morris et al., 2014) suggests that individuals in a community
eventually become highly dependent on each other through gene loss. There are plenty of
examples to support this point of view. For example, free radicals (ROS) are common
byproducts of normal metabolism. Most bacteria would produce superoxide dismutase,
catalase, and peroxidases to remove ROS. Some bacteria, such as Clostridia,
Ruminococcus, and Bacteroides, do not produce these detoxifying enzymes. They take
advantage of the ROS-free environment created by the other bacteria in the gut to avoid
oxidative damage. Keystone species, such as the Ruminococcus bromii (Ze et al., 2012)
benefit other bacteria by initiating the breakdown of dietary fibers and resistant starches.
Many bacteria in the gut cannot utilize the carbohydrates unless partially digested by
such species (Ze et al., 2012). Keystone species like R. bromii are in limited number in
the gut and lack protective enzyme such as catalase to protect themselves against
oxidative damage. Environmental pollutants, including antibiotics, can kill such keystone species by oxidative stress resulting in the death of bacteria dependent on them due
to starvation (Mayer, 2016). The loss of these downstream species provides an
opportunity for colonization by other microbes with an unpredictable outcome.
The adult gut microbiota is diverse. Therefore, the loss of a subset of the
microbiota due to smog is less likely to affect the overall networks of the microbiota.
However, an infant’s gut microbiota are much less diverse (Koenig et al., 2011).
Phylogenetic studies of a large number of healthy babies show that the species diversity
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of the microbiomes increase gradually over time (Koenig et al., 2011) . Early dysbiosis
of the gut microbiome of changes the succession profile of the infant’s gut microbiota.
This can produce mistaken signals to the brain, leading to many future health problems.
Collins Proposed mechanism is controversial propose a physiology-based approach:
Although, Collins proposed unifying mechanism sounds plausible the debates on
whether the proposed mechanism of antibiotic-induced cell death is due to the activation
of Reactive Oxygen Species (ROS) is still controversial. Research done in 1953
contradicts this claim where bacterial protoplast was grown in presence of the penicillin
in an isotonic solution. Considering the proposed mechanism to be true, the protoplasts
would have generated ROS molecules which would oxidize the membrane and denature
proteins, thus killing the protoplast. However, they found that the protoplast grew well
and duplicated. While some other researchers did not detect ROS molecules when
bacteria were treated with antibiotics (Keren et al., 2013; Y. Liu & Imlay, 2013; Y. Liu et
al., 2012). This controversy is helping us to expand our understanding of the complex
mechanisms by which antibiotics kill bacteria. We believe that the controversial results
referenced above are due to the following reasons:
I. Inappropriate choice of a model organism.
II.

Not addressing bacterial physiology.

III.

Unoptimized environmental factors.

To address the above-mentioned reasons, we have chosen the following solutions.
Azotobacter as a model organism
The physiology-based approach can answer the varying susceptibility of bacteria
towards antibiotics. For this purpose, we need to select a suitable model organism. The
9

current debates on whether ROS is or not a common pathway for the antibiotic killing of
bacteria are based on the study of Escherichia coli. It should be noted that E. coli is a
facultative anaerobe. This bacterium can grow aerobically with oxygen as its final
electron acceptor. The bacterium can also respire anaerobically with nitrate as the
electron acceptor. Without nitrate, the bacterium can grow fermentatively and produces a
variety of fermentative products and hydrogen gas. We believe that selecting E. coli as a
model organism to show ROS and oxidative stress may not be suitable because the
oxidative stress levels of aerobic respiration; anaerobic respiration, and fermentation are
very different. Thus, the different observations (or the lack of detection) of antibioticinduced ROS by different research groups may be simply because their E. coli cultures
were grown in different conditions.
To prevent this bias, we select a strictly aerobic bacterium—Azotobacter
vinelandii as our model organism. The advantage of using A. vinelandii as a model
organism for the analysis of antibiotic-induced ROS are plenty:
It is an obligate aerobe and therefore has an only aerobic mode of respiration. It
has the highest rate of respiration among all the cells known. Respiration is directly
linked to the production of free radicals and, therefore, a higher rate of respiration means
a higher amount of free radical generation.
The respiration rate of this bacterium varies depending on Nitrogen fixing
condition (J. Liu et al., 1995). Biomass varies in this bacterium depending on carbon
source (Wong, 1988).
It is very similar to a known pathogen (Pseudomonas). Based on 16s rRNA A.
vinelandii is even more similar to Pseudomonas aeruginosa than the other Pseudomonas
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species while it is clustered together with Pseudomonas species in pan-genome family
tree (Ozen & Ussery, 2012). These findings suggest that A. vinelandii has a
Pseudomonas-like backbone with several conserved genes. Findings from this bacterium
should supply valuable information to treat Pseudomonas infections.
Environmental factors affect the physiology of the bacteria and its response to
antibiotics.
The physiology of the bacteria depends on environmental factors. In the case of A.
vinelandii, we have previously found that biomass and rate of respiration are different
depending on whether the bacterium is growing on glucose or galactose. A. vinelandii is a
nitrogen-fixing bacterium and if nitrate is present in its growth medium then nitrogen
fixation is not performed. Nitrogen fixation is a very energy-expensive process and keeps
the bacteria stressed. While in presence of the nitrate that stress is relieved since nitrogen
fixation is not needed anymore. These differences in the physiological state of the
bacteria can decide the fate of the response to the antibiotics. Depending on the growth
medium and growth conditions, the same bacteria may be less or more sensitive to a
particular antibiotic. In chapter 2, we use change several environmental factors and study
the interaction of such factors that changes bacterial susceptibility. Finally, we perfect the
significant factors to get the best concentration of the factors that can give the bacteria
highly sensitive the antibiotics.
Using full factorial design and response surface method to optimize the
environmental factors.
Several factors affect the drug-target interactions, and such factors can decide the
fate of the drug action. For example, different metal ions present in the environment like
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chromium (Cr), copper (Cu), iron (Fe), nickel (Ni), and vanadium (V) have the potential
to produce Reactive Oxygen Species (ROS) in biological systems. These metal ions can
also interfere with various cellular functions and further interfere with drug-target
interaction. Such ROS molecules can in turn damage lipids and DNA. Depending on the
environmental growth factors, bacteria can become resistant or susceptible to a particular
antibiotic. Therefore, in chapter 2 we design a study to tune the physiology of bacteria
such that their susceptibility towards antibiotics increases. We use a full factorial design
to modulate the bacterial physiology and optimize the growth factors to make the bacteria
more susceptible to antibiotics.
Role of environmental pollutants (Triclosan) in antibiotic efficacy:
Although, optimized parameters of the significant factors do make the bacterium
highly sensitive, in real life other environmental pollutants also come into play. Several
such environmental pollutants interfere with the mode of action of antibiotics in bacteria.
Recently, Triclosan (TCS) has gained much attention for its interference with antibiotics.
TCS is extensively used in a wide variety of products that are used by humans in
everyday life. Such extensive exposure to the non-antibiotic antibacterial chemical has
been a great concern in human health. In chapter 3, I discuss the mechanism of action of
triclosan, its clinical application, its interaction with other antibiotics, and its effect on
human health. Then in chapter 4, I systematically analyze the interaction of this toxic
chemical with different antibiotics in several different bacteria and analyze the observed
cross-resistance.
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Chapter 2: Enhancing antibiotic efficacy through factorial design.
Introduction:
Antibiotics are the most recent medications that either kill the bacteria
(bactericidal) or keep them from reproducing (bacteriostatic). Antibiotics generally target
unique components found only in bacteria such as: inhibit DNA/RNA replication and its
repair system (norfloxacin); damage unique structure of the peptidoglycan cell wall and
inhibit cell wall synthesis (ampicillin); inhibit the 70S bacterial ribosome function targeting the 30S (tetracycline and kanamycin) or 50S ribosome subunits (erythromycin
and chloramphenicol); and inhibit a specific biosynthetic pathway such as folate
synthesis (trimethoprim) [1]. While these understandings of the immediate antibiotictarget interactions are generally well-documented, the subsequent processes leading to
the final death of the bacteria are less clear and are hotly debated recently [1]. Recent
evidence has shown that all bactericidal antibiotics, regardless of their drug-target
interactions, share a common mechanism to cell killing by generating disadvantageous
cellular responses called reactive oxygen species (ROS) [2-5]. These pieces of evidence
suggest that hydroxyl radical (the most potent ROS) formation is induced by bactericidal
antibiotics towards the end of the oxidative pathway. Destabilization of iron-sulfur
clusters that stimulates the Fenton reaction is thought to be the major pathway towards
the production of ROS due to antibiotic treatment. ROS leads to cellular damage and
ultimately cell death [5]. However, there is experimental evidence that contradicts this
hypothesis [6-8].
We reviewed the above arguments and proposed that many of the differences
observed by different groups of researchers are due to (A) the selection of the wrong
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model organism, and (B) the omittance to consider the physiological state of the bacteria.
ROS are formed largely through oxidative respiration. The model organisms used by
these researchers are facultative anaerobic organisms. Their rates of respiration, and thus
ROS formation, changes are highly affected by the chemical and physical conditions
provided.
Herein we present the efficacies of several classes of antibiotics to an obligate
aerobic bacterium, A. vinelandii, grown under different environmental conditions. We
used full factorial design and response surface methodology (RSM) to demonstrate how
to optimize the environmental growth factors to promote the antibiotics.
Methods:
Selection and culture of a model organism.
Azotobacter vinelandii OP was selected as model organism in this study. It was
always grown in 50 ml Burks N free medium at pH 6.2 in 500 ml Erlenmeyer flasks
unless specified otherwise. Media was supplemented with 2% sugar and incubated in a
shaker incubator at 30 oC for 24-36 hours at 250 rpm.
Selection of factors affecting antibiotic sensitivity.
Many physical and chemical factors can affect the growth of bacteria. Factors like
carbon source, ion concentrations, temperature etc. can change the lipid composition of
gram-negative bacteria [9, 10] leading to altered sensitivity of the bacteria to antibiotics.
Interaction between these factors affecting the sensitivity of bacterium to antibiotics is
largely unknown. We selected carbon sources; divalent ions, pH, and fixed-nitrogen vs
free-nitrogen growth conditions as variables to test our hypothesis:
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A. vinelandii was grown in Burks N-free agar plates (2% agar) by overlay
method. In Burks N free solution with 0.5% agar, bacterium inoculum was mixed and
covered the top of the Burks N free agar plates. The paper disc containing 10µg of a
specific antibiotic was then placed on top of the agar plates. Plates were incubated at 30
o

C for 24-36 hours and the zone of inhibition was measured.
Seven different classes of antibiotics were chosen viz: Ampicillin, Tetracycline,

Kanamycin, Chloramphenicol, Erythromycin, Trimethoprim, and Norfloxacin.
Seven carbon sources viz: glucose, fructose, galactose, sucrose, maltose,
mannose, and lactose. Carbon sources were used at a 2% final concentration in the plates.
Magnesium sulfate, Calcium chloride, Zinc sulfate, Iron Sulphate, and Manganese
chloride were added in Burks N free agar plates at different concentrations to study the
effect of metal ions and trace elements.
The bacterium was grown at pH 5, 6, 7, and 8 to study the effect of pH, Potassium
nitrate (40mM final concentration) was added to the N-free medium for growth under
fixed-nitrogen grown conditions.
Screening of the factors
Preliminary screening of the factors was done by testing each of the abovementioned variables on the Burks N free agar plate. Factors (see below) that showed
significant change in antibiotic sensitivity (Zone of Inhibition) were further analyzed in
the factorial design process.
Factorial design
Full Factorial design at 2-level (2k) was used to find the effect of the factors and
their interaction on the sensitivity of bacteria to antibiotics. Six factors were chosen as the
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significant factors from the screening process. A total of 64 runs (64 different
combinations) were set up as the full factorial design. Burks N free agar plates with a
different carbon source (Glucose or Galactose) and different pH (pH 6 or 7) were made.
The Mid-log phase of A. vinelandii was taken and OD was adjusted to 0.5 at 600nm. The
inoculum was overlayed on Burks N free agar plates. After solidification, wells were
made (0.6mm in diameter) in the plates and different combinations of other remaining
factors including antibiotics were added to the wells as shown in figure 1. The plates
were then incubated at 30 oC for 24-36 hours and the zone of inhibition was measured.
The area of the inhibition was calculated from the zone of inhibition which was used as a
response variable.

Figure 1. Burks Nitrogen agar plates with wells for factorial design set up.
General linear regression was used to analyze the factorial data. A full linear
model was built with two-level of interaction and three-level interaction between all
factors. AIC based backward selection method was used to build the final model.
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Optimization of factors.
The factorial design experiment allows us to identify the significant interaction
between the factors. Response surface methodology and Contour surface plots under the
R package (persp) were used to analyze the interaction between the factors. Optimization
of the factors with significant interaction was done at various levels of each factor.
Enzyme assay
Bacteria produce antioxidant enzymes to overcome oxidative stress. Measurement
of antioxidant enzymes in a bacterial cell provides information about the state of
oxidative stress in the bacterial cells.
Catalase assay was measured spectrophotometrically at 240nm in a quartz cuvette
according to Aebi, H [11]. Briefly, A. vinelandii was grown in Burks N-free media with
glucose or galactose as a carbon source for 10-14 hours until it reached the mid-log
phase. OD of cells was adjusted to 0.4 at 600nm and then treated with either
erythromycin or kanamycin. Treatment was done at 2ug/ml concentration. After
antibiotic treatment cells were further incubated for 8-10 hours and harvested. Cells were
pelleted by centrifuging at 15000 rpm for 5 minutes and washed with PBS (Phosphate
Buffer Saline, pH 7.4) three times then resuspended in the same buffer. OD was adjusted
to 0.24 at 600 nm and total cell counts were estimated by direct microscopic count using
Petroff-Hausser counting chamber. A solution of 0.6 ml of the resuspended bacterial and
0.3 ml Phosphate buffer saline (PBS) was used as the baseline. Parallel studies, using
0.3ml of 60mM hydrogen peroxide to replace PBS was used for the catalase activity. The
decrease in OD at 240 nm was recorded over time. Specific catalase activity was
expressed as moles of hydrogen peroxide removed by 1010 cells in a minute.
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Statistical test
R-statistical programming language (The R Foundation for Statistical Computing,
Vienna, Austria, version 4.0.3) was used to run the statistical analysis and to make the
plots. Kruskal Wallis test was done to find the significant difference between groups.
Post hoc pair wise comparison was done between group levels using Holm correction.
The p < 0.05 is considered as statistically significant difference.
Results:
Effects of carbon sources.
In this study, we tested the effect of 7 different carbon sources on the sensitivity
of A. vinelandii to antibiotics. A. vinelandii did not grow in Lactose and Mannose. We
found that interactions between the types of carbon-source and the types of antibiotics are
highly related. For example, erythromycin is an antibiotic that inhibits protein synthesis
by binding to the 23S ribosomal RNA molecule in the 50S subunit of ribosomes of the
bacteria. The galactose-grown A. vinelandii is significantly more sensitive to this
antibiotic than cultures growing in glucose, fructose, and other disaccharides such as
sucrose, and maltose (Figure 2a). Kanamycin also inhibits protein synthesis by interfering
with the 30S subunit of the bacterial ribosome. Despite using a similar mechanism of
protein synthesis inhibition, Galactose- and sucrose-grown cells are highly sensitive to
kanamycin, whilst glucose- and fructose-grown A. vinelandii are less sensitive to
kanamycin. A. vinelandii growing on maltose is least sensitive to kanamycin (Figure 2b).
Variations of the type of carbon source affecting antibiotic sensitivity do not seem to be
restricted at the level of protein synthesis. Norfloxacin inhibits the DNA gyrase and
prevents DNA replication of the bacteria. Galactose- and glucose-grown A. vinelandii are
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highly sensitive to norfloxacin whereas fructose-grown cells are least sensitive the
norfloxacin (Figure 2c).
Based on these observations, we selected galactose for the rest of the experiment.
Glucose was also used side by side in the rest of the experiments for comparison.

Figure 2. Effect of different carbon sources in sensitivity of bacteria to antibiotics a)
erythromycin, b) kanamycin and c) norfloxacin. A. vinelandii did not grow in lactose and
Mannose.

Effects of metal ions and trace elements
Salts of calcium (calcium chloride), magnesium (magnesium sulfate), manganese
(manganese chloride), molybdenum (sodium molybdate), and iron (ferrous sulfate) were
used to study the effects of metal ions on the sensitivity of bacteria to antibiotics. The
effects of these ions were also different depending on the type of antibiotic used. All
tested metal ions made bacteria more sensitive to Kanamycin with its increasing
concentration. Increasing concentration of calcium decreased the sensitivity of bacterium
to erythromycin but increased the sensitivity to kanamycin (figure 3). In the case of
norfloxacin, increasing the concentration of calcium increased the sensitivity of
bacterium when glucose was the carbon source but did not alter the sensitivity when
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galactose was the carbon source. Like calcium, increasing the concentration of
magnesium decreased the sensitivity of bacteria towards erythromycin and towards
norfloxacin, but increased the sensitivity towards kanamycin (figure 4). The bacterium
did not grow in a higher concentration of manganese. The presence of manganese
increased the sensitivity of the bacterium to all three antibiotics while its absence
decreased it (figure 5).

Figure 3. Effect of calcium in sensitivity of A. vinelandii to antibiotics a) erythromycin,
b) kanamycin and c) norfloxacin.
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Figure 4. Effect of Magnesium in sensitivity of A. vinelandii to antibiotics a)
erythromycin, b) kanamycin, and c) norfloxacin.

Figure 5. Effect of Manganese in sensitivity of A. vinelandii to antibiotics.
Effect of pH
The bacterium did not grow in pH below 5.5 and above 7.5. Therefore, our study
was conducted at the two pH levels (6 and 7). The sensitivity of bacterium was higher at
pH 7 than at pH 6 consistently among all three antibiotics tested irrespective of the
carbon source (figure 6).
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Figure 6. Effect of pH in sensitivity of A. vinelandii to antibiotics a) erythromycin, b)
kanamycin and c) norfloxacin.

We should emphasize that our investigations of a single factor affecting the
killing of an antibiotic, such as those presented above (Figures 2-6), could be misleading
because these factors are all essential for the growth of A. vinelandii. How these factors
interact together in the presence of antibiotic is more complicated. A full-factorial-design
experiments could allow one to investigate the major factors in affecting the inhibition of
antibiotics.
Factorial design
Factorial design is one of the best ways to study the effect of various factors in a
system. We used a two-level full factorial design to study the effect of environmental
growth factors that changes the sensitivity of bacteria to antibiotics as shown in table 1.
Factors were set at high and low levels and all-possible combinations were assessed
through measurement of the area of the inhibition zone (Figure 1).
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Table 1. Variation in studied factors.
Range and level
S.N. Variables
0
1
Sugar
Galactose (2%)
2
Mannose
0
3
Calcium
1mM
4
Magnesium 1mM
5
pH
6
6
KNO3
0mM

1
Glucose (2%)
1%
10mM
10mM
7
40mM

Figure 7 shows the summary of the final linear model for kanamycin. The pH
variation (pH 7 vs pH 6) is a major factor for the action of kanamycin. When the pH data
are analyzed separately, it shows that at pH 6, interactions between calcium and nitrate
are highly effective in promoting kanamycin-induced inhibition in both glucose- and
galactose- grown cells (Figure 8 ). However, Mg is the second most important factor in
promoting the kanamycin in glucose-grown cells. The interactions between Ca:Mg is the
second most important factor in promoting the kanamycin in galactose-grown cells.
Whereas, interactions of Ca:Mg and Mg:NO3 would negatively affect the action of
kanamycin in glucose-grown cells at pH 6 (Figure 8a). NO3 alone is a major factor
affecting action of kanamycin in only galactose-grown cells at pH 7(Figure 8c) while it
affects negatively in the rest of the cases. At pH7, interactions between Ca:Mg and Mg:
mannose are the major factors positively affecting the action of kanamycin in glucoseand galactose-grown cells, respectively. Interactions between Mg:NO3 is the major factor
negatively affecting the action of kanamycin in both glucose- and galactose-grown cells
at both pH.
It is possible to extend our model to examine three-component interaction in
affecting the action of kanamycin (Appendix I, Supp. Figure 3) and erythromycin
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(Appendix I, Supp. Figure 6). However, at current setup, these interactions become too
complex, and their significances become questionable.
Similar set up for erythromycin was also done and we found that pH and sugar
were the most significant factors positiviely affecting the sensitivity of bacterium while
the interaction between them was the most significant factor to negatively affect the
sensitivity (Appendix I, Supp. Figure 4). Further breakdown of the final model with
respect to sugar and pH suggested similar findings as observed in kanamycin treated
cells. However, number of factors that significantly affected the sensitivity of bacteria
was less in case of erythromycin treated cells (Appendix I, Supp. Figure 5).

Figure 7. Pareto chart of the final linear model for kanamycin treated cells with two
level of interaction.
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Figure 8. Pareto chart of final linear model for kanamycin treated cells when a) pH is 6
and carbon source is glucose, b) pH is 6 and carbon source is galactose, c) pH is 7 and
carbon source is glucose, and d) pH is 7 and carbon source is galactose.

Optimized environmental factors.
Response surface methodology was used to optimize the conditions for making
the bacteria most sensitive to antibiotics. Based on linear model analysis from the final
model, the RSM study was done among two interactions: pH and carbon source; and
magnesium and carbon source. Increasing the concentration of magnesium decreased the
sensitivity of the bacterium to erythromycin irrespective of the carbon source. However,
the effect was more pronounced when galactose was the carbon source. For
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erythromycin, 1.5% of carbon source of either of the carbon source with no magnesium
are the optimum concentrations to make the bacteria most sensitive (Appendix I, Supp
Figure 1 a:d). In the case of kanamycin, increasing the concentration of magnesium made
the bacteria more sensitive to antibiotics under either of the carbon sources. 1% of
glucose and 5-10 mM of magnesium are the optimum concentration to make the bacteria
most sensitive to kanamycin. While 1.5-2% of glucose and 10mM of magnesium are the
optimum concentration to make the bacterium most sensitive to kanamycin (Appendix I,
Supp. Figure 1 e:h).
In the case of pH (Appendix I, Supp. Figure 2), higher pH was more effective in
making the bacterium more sensitive overall. 1.5% of galactose at pH 7 and 1% of
glucose a pH 6.5 made the bacterium most sensitive to erythromycin. Similarly, for
kanamycin, bacteria were most sensitive with 1.5% galactose at pH 6 or 0.5-1.5%
galactose at pH 7-7.5. However, when glucose was the carbon source, sensitivity to
kanamycin was most at 1% at pH 7.5.
Catalase assay:
Catalase assay was done according to Aebi, H [11]. Briefly, the bacterium was
grown either in glucose or galactose, and an antibiotic, either kanamycin or
erythromycin, was added in the mid-log phase. Cells were grown in presence of
antibiotics for 8-10 hours then harvested and catalase assay was performed. Catalase
assay provides a measure of the antioxidative status of the cell. Bacteria exposed to
erythromycin had significantly higher levels of catalase activity, almost 4-5 times than
that of untreated cells and kanamycin-treated cells. Kanamycin-treated cells did not have
increased catalase activity when compared with the untreated ones. However, the
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difference in the carbon source also affected the catalase activity, more clearly in
kanamycin-treated cells.

Figure 10. Catalase activity of A. vinelandii with and without antibiotics.

Discussion:
Most of the ROS are produced through aerobic respiration where electrons from
the electron transport chain were added to the molecular oxygen, one electron at a time,
leading to the formation of superoxide, hydrogen peroxide, and hydroxyl radicals. The
electron transport chains of bacteria are blanched [12] and the rate of the electrons to a
particular branch is often influenced by many factors [13]. Facultative anaerobes, such as
Escherichia coli can alter their mode of metabolism readily: from fermentation to
anaerobic respiration to aerobic respiration. These various changes of metabolism make it
hard to access the effect of ROS on cell death. Azotobacter vinelandii is an obligate
aerobic bacterium that belongs to the Pseudomonadaceae Family of the proteobacteria.
The organism has the highest rate of respiration among all known bacteria when grown
under nitrogen-fixing conditions due to the need for oxygen-protection of the otherwise
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oxygen-sensitive nitrogenase [12, 14]. The rate of oxidation of this organism can be
greatly reduced by growing under the non-nitrogen-fixing condition in the presence of
nitrate. Also, the glucose-grown cells respire more rapidly than the galactose-grown cell
[13, 15, 16]. The limited mode of respiration and the many tools available to regulate
respiration rate make this bacterium ideal to reexamine the various issues of ROS in
bacterial killing. It is genetically very similar to P. aeruginosa and therefore findings
obtained from this bacterium should provide insights that can help in treating P.
aeruginosa infection [17].
Carbon sources are a major growth factor for heterotrophic growth. Depending on
the types of carbons provided, bacteria often respond completely differently. Kyle R.
Allison and colleagues have demonstrated that specific nutrients can potentiate
aminoglycoside killing of persisters. They found that metabolites entering the initial
glycolysis and pyruvate pathways increase in proton-motive force, which helps the
transport of the antibiotic into the cell. The increased activity of the antibiotic inside the
cells subsequently leads to cell killing. They also observed that persisters upon
stimulation by nutrients do not revert to normal growing cells. In absence of stimulation
from specific nutrient they stay as persisters and hence are not sensitive to the quinolone
or B-lactam antibiotics [18]. Conrad et al in their study also found that carbon sources
can change the polymyxin B sensitivities in Pseudomonas aeruginosa. According to
them, P. aeruginosa was more resistant when the cells growth medium was enriched with
d-glucose or l-glutamate as compared to Mueller-Hinton medium or medium with Lisoleucine, L-leucine or L-valine alone [19].
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Bacteria are exposed to mixed sugars in the real world. We used mannose as
additional carbon source along with glucose and galactose in the factorial design.
Mannose is a poor carbon source for A. vinelandii and it prefers glucose or galactose to
mannose. Under nitrogen fixing condition, when energy demand is very high for the cell,
mannose cannot provide enough energy for cell growth. However, when hydrogen is
supplied as energy source then A. vinelandii uses mannose as carbon source. We
observed that mannose negatively affects action of kanamycin (Figure 10). However, at
pH 6 with galactose and pH 7 with glucose, presence of mannose under fixed N2
condition (KNO3: mannose), efficacy of kanamycin increased (Figure 11b and 11c).
Under N2 fixing condition, because of high energy demand, it is possible that the
bacterium did not use mannose but in fixed N2 condition, bacterium can use mannose.
Fixed N2 condition seems to make bacteria less sensitive to kanamycin than N2 fixing
condition, except when growing on glucose at pH 7 (Figure 11c).
Besides the types of sugar, other chemical factors, such as calcium (Fig 3);
magnesium (Figure 4), and manganese (Figure 5) can influence the efficacies of the
abovementioned antibiotics. Calcium and magnesium are alkaline-earth-metal ions that
are physiologically essential for diverse living organisms. Although role of calcium in
eukaryotic cell signaling is well documented, its role in prokaryotes is less studied.
Researchers have found that ribosome targeted antibiotics cause destabilization of
ribosome which results in hyperpolarization of bacterial cells. Higher extracellular
calcium and magnesium levels have been found to counteract hyperpolarization of
bacterial cells and stabilize the ribosomes. This increases the stress resilience in bacteria
against the ribosome targeted antibiotics and promote survival [20]. Similarly, reduced

29

concentration of magnesium inside the bacterial cell can cause disintegration of the
ribosomes. Cells may not be able to reutilize the ribosomal proteins released from the
ribosome to form new subunits if the magnesium concentration is very low [21].
Increased intracellular calcium concentration are also reported to increase the expression
of protective enzymes like oxide dismutase, ascorbate peroxidase, glutathione reductase
and peroxiredoxin [22]. We observed decreased sensitivity to erythromycin with
increasing concentration of calcium and magnesium (figure 5 and 6). It seems to be true
for norfloxacin as well since magnesium binds the DNA and increases its stability thus
providing improved survival against norfloxacin. Norfloxacin also binds metal ions
forming complexes. Kanamycin also has similar mechanism of protein synthesis
inhibition as erythromycin. However, we found that increasing concentration of
magnesium and calcium increased the sensitivity to kanamycin. From linear modeling we
observed that calcium and magnesium does improve the efficacy of kanamycin but, they
also interact with other factors like pH, sugar, and nitrate to decrease the efficacy (figure
10).
Physical factor, such as pH is also an important factor affecting the efficacies of
the abovementioned antibiotics (Figure 6). A. vinelandii were more sensitive when grown
in higher pH than in lower pH. In fact, we found that pH was solely responsible for the
50% of the efficacy of kanamycin from linear modeling. Nevertheless, its interaction with
calcium and sugar are the major factors to negatively affect the efficacy of kanamycin.
First, pH affects the permeability of bacteria cell wall to antibiotics [23]; the stability and
activity of enzymes which may interact with antibiotics; and stability and kinetics of
antibiotics [24]. Secondly, concentration of protons is higher at lower pH. So, when the
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environment has lower pH, more protons from the environment can enter the bacterial
cell. These protons can neutralize the negatively charged ROS molecules inside the cell
and decrease the possible damage by ROS. This possibly explains why pH is the major
contributing factor in efficacy of kanamycin.
Our studies on the chemical and physical environments affecting the efficacies of
various antibiotics thus support the notion that antibiotic-induced bacterial death is
beyond the initial antibiotic-protein interaction [5]. However, our studies do not support
the notion that ROS is a uniform cause of antibiotic-induced bacterial cell death.
Unlike using the facultative anaerobe E. coli as a model, we used an obligate aerobic
bacterium as a model organism to reduce complications associated with the facultative
anaerobe. Previous studies show that glucose-grown A. vinelandii respires much faster
than galactose-grown cells [13]. Since the majority of ROS in the cell is produced during
aerobic respiration, cells growing in glucose should be exposed to a much higher
oxidative stress than cells growing in galactose. One may argue that Glucose-grown cells
may produce a higher pool of antioxidative enzymes to keep oxidative balance inside the
cell. This decreases the extent of the damage caused by antibiotics and hence renders
bacterium less sensitive to antibiotics. However, this may not be true for all antibiotics.
We observed this difference in sensitivity based on glucose or galactose as carbon source
for ribosome targeted antibiotics like erythromycin and kanamycin. In case of DNA
targeted antibiotic norfloxacin, the sensitivity profile was almost similar in both glucose
and galactose grown cells (Figure 2). Our study highlights the importance of the
interaction between environment-bacteria-antibiotic complex system to better treat the

31

bacterial infections. Our approach provides quick and simple way for such study and
effective way to analyze the outcome of antibiotic treatment.
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Chapter 3: Triclosan: antimicrobial mechanisms, antibiotics interactions, clinical
applications, and human health
Introduction:
Triclosan (2,4,4’ –trichloro-2’-hydroxy diphenyl ether) is a chlorinated aromatic
compound (Fig. 1). Early assumption that Triclosan, being a nonpolar molecule and a
strong protonophore, would act very much like the alcohols. The compound would bind
to the hydrophobic environment such as the lipid membrane. Therefore, inserting
Triclosan to the lipid bilayer would depolarize the membrane, leading to cell death. The
first US patent for Triclosan was issued to Ciba-Geigy in 1964 1 and other brand names
of Triclosan such as Irgasan® PG60; Irgasan®DP 300; Lexol 300; Ster-Zac,
Cloxifenolum, and Kopsan are still commonly used commercially. Trade brands such as
Microban and Biofresh often have Triclosan as antimicrobial embedded in acrylic fibers
(EP2893813A1 European Patent Office). About 10 million pounds of Triclosan were
produced annually in 2015 globally.2 Triclosan is produced by many chemicals and
pharmaceutical companies around the world. Major producers of this compound include
BASF (USA); Kumar Organic (India); Vivimed Labs (India); Dev Impex (India); Xian
Medihealth (China); Spectrum Chemical (USA); Pierre Fabre Dermo Cosmetique
(French); Buntech - Tecnologia em Insumos (Brazil); Salicylates and Chemicals (India);
Suraj Impex India Pvt (India); Jiangsu Equalchem (China); Sino Lion (USA); Jiangsu
Huanxin (China); Hunan Lijie Biochemical (China); Shandong Aoyou (China); Hubei
Xiangyun Chemical (China); Yichang Yongnuo Pharmaceutical (China).
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Figure 1. Chemical structure of Triclosan.

Early on, Triclosan was claimed to work against bacteria and fungi. The evidence
showed that Triclosan in Colgate Total toothpaste was effective in preventing gingivitis.3
Triclosan was later added to mouthwash, bar soap, liquid soap, shower gels, facial
washes/cleansers, hair shampoos, underarm deodorants, shaving creams, after-shave
lotion, and anti-acne preparations. Because Triclosan is hydrophobic, the compound can
be applied to many plastic products for industrial and commercial applications. These
include conveyor belts, water hoses, Heating Ventilation and Air Conditioning (HVAC)
coil, ice-making tubing, glues, fabrics, vinyl, and other plastics and clothing, porous
plastic filters, floor wax, clothing, kitchenware, furniture, toys, caulking and sealant
compounds, and some latex paints to prevent microbial growth and as an odor-controlling
agent in clothing (European patent Office EP1714664A2). It should be noted that
cosmetics, body wash, soap, and toothpaste products are regulated by the FDA in the
United States. Other products like clothing, kitchenware, furniture, and toys are not
regulated by the FDA.
Like many man-made compounds such as pyrrolizidine alkaloids 4 and other
environmental pollutants,5 there are great concerns in the persistence of Triclosan in the
environment.6-10 In September 2016, the FDA issued a new rule
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(https://www.fda.gov/drugs/information-drug-class/qa-consumers-health-care-antiseptics)
stating that over-the-counter antiseptic wash and soap products that contain Triclosan
(and 23 other compounds) can no longer be marketed. This ruling seems to reflect the
current consensus that extensive use of Triclosan-added soaps could induce bacterial
resistance, but the products do not seem to add sanitizing benefits over plain soaps.11, 12
Despite its negative images, Triclosan can be beneficial. For example, it was shown that,
although Triclosan has no direct and immediate role in preventing infection for the
mothers, the use of Triclosan-containing wash produces often reduces the antibiotic
prescription in infants with respiratory illness.13 In the same study, the authors reported
that Triclosan-usage group infants could significantly reduce their doctor visits than the
non-Triclosan-usage group of infants. Besides, Triclosan exhibits both synergistic and
antagonistic effects with other antibiotics (see below).
There are excellent reviews on various subjects concerning Triclosan in recent
years.2, 14 Since these publications, the interest in Triclosan remains high. A search in
Google Scholar on “Triclosan” since 2017 shows more than 14,000 hits. Similarly, a
Scopus search reveals more than 78,000 new documents on Triclosan in the last three
years. The subject of this literature review focuses mainly on the literature from 2017 to
2020. We wish to concentrate on the interactions of Triclosan to the bacterial pathogens,
humans, as well as the clinical applications of this compound. The benefit and risk of
this compound and the author's opinion and perspective of this compound have been put
forward.
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Targets of Triclosan in bacteria:
Triclosan exhibits multiple targets against a living cell. This detergent-like
compound can interfere with the stability and topology of lipid and protein structures.
Disruption of the integrity of the membrane may also explain why many enveloped
viruses, including the influenza A virus 15 and the murine hepatic viruses 16 are sensitive
to Triclosan. The hydrophobicity of Triclosan may disrupt the protein structure, and thus
inhibit its biological function.17 This could explain superoxide dismutase;18 the nonenveloped Norovirus; 19 Adenovirus (type 5) and Poliovirus (type 1) 20 are sensitive to
Triclosan.
In addition to the alcohol-like property, many studies showed that Triclosan has a
more specific target in bacterial proteins— the fatty acid synthesis.21
The fatty acid synthesis process is conserved in most organisms: The acetyl-CoA
is the initiating substrate adding to the malonyl-CoA. The last step in the elongation
process is the reduction of the substrate enoyl-thioester to an acyl moiety. However, there
is a difference between that found in animals and some yeast, and those found in plants,
and bacteria. Type I fatty acid synthase (FASI) is a protein found in animals and many
yeasts. The FASI is a large multifunctional homodimeric protein that has all the
enzymatic activities required in the pathway. In contrast, most bacteria, plants, and
mitochondria (which is evolved from bacteria through the process of endosymbiosis)
produce their fatty acids by the type II fatty biosynthetic pathway 22 (Fig.2). Instead of a
single multifunctional protein, the FAS II is a group of single-function proteins. The
complex includes AccABCD (the acetyl-CoA carboxylase); FabD (moleyl-CoA: ACP
transacylase); and FabH (the 3-ketoacyl-ACP synthase I, II and III); FabG (the 3-
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ketoacyl-ACP reductase); FabA and FabZ (the 3-hydroxyacyl-ACP dehydrase); FabI
(enoyl-ACP reductase); FabB and FabF (the 3-oxoacyl-acyl-carrier protein synthase
I/II).23

Figure 2. Sites of Triclosan inhibition. Besides the less-specific hydrophobic
interactions of Triclosan with lipids and proteins, Triclosan can specifically interact with
the FabI and FabB/F proteins, interfering with the lipid biosynthesis process and biofilm
formation, respectively; Triclosan can also bind to an efflux pump repressor of a
bacterium, leading to the activation of multidrug efflux pumps-induced
antibiotics/Triclosan resistance.
Triclosan is a FabI inhibitor in the presence of NAD+.21 FabI, which code for the
enzyme enoyl-[ACP] reductase [NADH], is the rate-limiting enzyme in the last step for
fatty acid biosynthesis in many bacteria. Triclosan depresses the substrate (trans-2-enoylACP) binding with FabI to hinder the fatty acid synthesis.24, 25 A similar enzyme, InhA an
essential enoyl acyl carrier protein reductase, found in Mycobacterium tuberculosis, is
also inhibited by Triclosan noncompetitively, resulting in the killing of M. tuberculosis.
26

Thus, Triclosan is a promising compound for the suppression of mycobacterial

growth.27-29
Triclosan probably has multiple targets against bacteria, for example, at a lower
concentration, Triclosan interferes with FabB, and thus preventing the bacteria from
forming colonies (but grew readily in liquid culture).30 Disallowing the bacteria from
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forming colonies may explain why Triclosan can prevent biofilm production.31 Triclosan
may also target multiple global regulatory systems in Staphylococcus aureus.32 The
metabolic network of Bacillus thuringiensis, as indicated by the changes in proteome and
phospholipid profiles, is altered in the presence of Triclosan.33
Resistance to Triclosan:
Interestingly, a homolog of FabI in Pseudomonas aeruginosa, called FabV,
confers Triclosan resistance on this bacterium.34 In addition to an altered FabI enzyme,
many bacteria may resist to Triclosan by pumping this compound out of the cell. In
Agrobacterium tumefaciens, the AcrAB efflux pump, a member of the so-called
Resistance-Nodulation-cell-Division (RND) superfamily,35, 36 confers resistance to
various toxic compounds, including antibiotics ciprofloxacin, nalidixic acid (NAL),
novobiocin and tetracycline, the detergent sodium dodecyl sulfate (SDS), and Triclosan.
Induction of the acrA transcript occurred when wild-type cells were exposed to NAL,
SDS, and Triclosan;37 Another member of the RND superfamily, the MultidrugResistance- Pumps (MDR) efflux systems, can export many structurally unrelated
substrates. Families of the MDR efflux pumps, such as the MexAB-OprM efflux system,
the MexCD-OprJ efflux system, and the MexEF-OprN efflux system in Pseudomonas
can remove Triclosan from the cells.38
Besides being one of the substrates of the MDR efflux pumps, Triclosan itself can
activate an MDR efflux pump. For example, in Stenotrophomonas maltophilia, Triclosan
can bind to the SmeT protein, a repressor of the MDR SmeDEF efflux pump, and activate
the efflux pump to remove Triclosan and other antibiotics39 (Fig. 2).
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Paradoxical Effect (also called the Eagle Effect) of antibiotics where bacterial
killing is reduced at antibiotic concentrations higher than Minimum Inhibitory
Concentrations (MIC) was discovered more than 70 years ago.40 Although there have
been extensive reports of such effect, our understanding of the mechanism responsible for
the Eagle Effect remains very poor.41 Shrestha et al. observed Enterococcus faecalis
exhibits two concentric growth zones in a Triclosan Disk-Diffusion assay.42 The authors
also showed that E. faecalis growing at the inner zone could expel EtBr, an indicator for
an MDR efflux pump, more readily. Their results suggested that the expression of the
MDR efflux pump in E. faecalis 43, 44 is Triclosan-concentration dependent. At high
Triclosan concentration, the bacteria would expel the drug using the MDR efflux pump
and prevent growth inhibition. However, as the concentration of Triclosan becomes more
diluted, the efflux pump would become less effective, leading the growth inhibition.
Their observation suggests that similar Eagle Effects observed in other antibioticpathogen interactions may be due to a similar mechanism.
So far, there are no reports of Triclosan resistant fungal species. However, fungal
metabolites can lead fungi to become partially or highly resistant to Triclosan. Enzymes
like laccase 45 can detoxify and transform the Triclosan into less toxic or nontoxic biproducts. Murugesan et al.46 showed that 56.5% of Triclosan was effectively removed by
laccase within 24h. The enzyme can oligomerize Triclosan or cleave ether bond followed
by dechlorination in the presence of redox mediators. Bacteria growing in such an
environment with fungi have the additional advantage to gain resistance against
Triclosan.
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Triclosan-drug Antagonist reactions:
Triclosan decreases the efficacy of carbapenem in Acinetobacter baumannii;24
Continuous exposure to a low level of Triclosan causes Escherichia coli to become
resistant to this compound.47
Several mechanisms are provided to explain how Triclosan reduces the efficacy
of antibiotics.
Staphylococcus aureus becomes more resistant to the otherwise lethal dose of
ciprofloxacin, rifampicin, or vancomycin in the presence of Triclosan. These resistances
are coinciding with the increased polysaccharide production in biofilm.32 It was proposed
that inhibition of fatty acid by Triclosan would result in the guanosine tetraphosphate
(ppGpp) accumulation.48 The accumulation of ppGpp, in turn, suppresses the TCA cycle
activity.49 Additionally, the accumulation of ppGpp also affects biofilm formation.50 The
decrease in metabolic activity and the formation of biofilm together may explain how
some bacteria become more resistant to antibiotics in the presence of Triclosan.
Another mechanism of Triclosan-induced antibiotic resistance in bacteria may be
related to mutations due to oxidative stress imposed by Triclosan. Long-term exposure to
a low dose of Triclosan can cause E. coli to induce mutations to genes such as fabI, frdD,
marR, acrR and soxR, and up-regulation of the transcription of genes encoding betalactamases and multi-drug efflux pumps.51
Triclosan may help cross-genera horizontal gene transfer. A report shows that even at
very low concentrations (0.02 to 20 μg/L), Triclosan could induce oxidative stress in E.
coli. In response to the stress, E. coli would activate its SOS response regulatory genes
umuC, and dinD, leading to the stimulation of inter-genera horizontal gene transfer of
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conjugative plasmid-encoded multi-resistance genes from the E. coli host to a different
species of bacteria (Pseudomonas putida).52 Besides, thus induced oxidative stress could
also accelerate the transformation of extracellular genes by damaging the bacterial
membrane.53
Shrestha et al. reported that Triclosan acts antagonistically with tetracycline and
norfloxacin against Pseudomonas aeruginosa and Stenotrophomonas maltophilla,
respectively.42 Their result shows that Triclosan can upregulate the efflux pump in these
bacteria, causing the bacteria to become almost completely resistant to certain antibiotics.
Triclosan-drug Synergistic reactions:
Triclosan can effectively reduce the biofilm-formation in Listeria species, as
compared with quaternary ammonium and ethanol-based sanitizers.54 Ethylene glycolpoly (beta-amino esters) micelles-conjugated Triclosan (PEG-PAE-Triclosan) has shown
to be a better agent in the killing of multi-drug-resistant S. aureus, E. coli, and oral
Streptococcal biofilms than Triclosan alone in animal studies.55 Cystic fibrosis (CF) is a
genetic disorder. The disease prevents the effective removal of substances in respiratory
airways, making the patient hard to breathe. The thick mucus traps P. aeruginosa and
leads to infections. Triclosan exhibits a synergistic effect with tobramycin, resulting in a
100-fold reduction of Pseudomonas within the biofilms in cystic fibrosis treatment;31 The
ceftazidime-resistant strain of Vibrio alginolyticus is characterized by its futile respiration
and pyruvate cycle, but shows an increased fatty acid biosynthesis, as compared with the
ceftazidime-sensitive strains. Disruption of the fatty biosynthesis by Triclosan would
make the resistant strains of V. alginolyticus more sensitive to ceftazidime.56 Triclosan
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exhibited a significant synergistic effect with ampicillin, erythromycin, and kanamycin in
Staphylococcus epidermidis.42
Clinical /commercial application:
Alfhili and Lee have recently summarized the biochemical and molecular
mechanisms of Triclosan in different organisms.57 Triclosan could help control
infections. Ley and colleagues showed that although Triclosan-containing wash products
could not reduce the infectious disease of the mothers, mothers using Triclosan products
needed fewer antibiotic prescriptions for their infants.13 Under a hydrophobic
environment, Triclosan can be loaded to polyurethane micelles to deliver the drug for the
treatment of bacterial infections and control biofilms.58 Many new ideas are being
considered for the use of Triclosan in the textile market.20, 59 Triclosan has been used for
cancer treatment. Triclosan is toxic to erythrocytes. It can induce hemolysis and
stimulating premature death, at least in part, through Ca2+ mobilization, and p38 MAPK
and the Receptor-Interacting serine/threonine-Protein kinase 1 (RIP1) activation. One of
the many cellular pathways of RIP1 may involve in the mediation of the p38 MAP kinase
response to cytokine tumor necrosis factor-alpha in cell death.60
Catheters:
Nosocomial infection often causes significant medical and economic
consequences. Catheter-associated urinary tract infection is a common nosocomial
infection in many hospitals.61 Many studies have shown that Triclosan is a good
antimicrobial compound used for catheter-coating.62, 63 For example, Proteus mirabilis
forms biofilms inside the urinary catheters and prevents the flow. A laboratory model of a
Foley catheterized bladder infected with P. mirabilis showed that when retention balloons
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were inflated with a solution of Triclosan (1%), the catheters drained freely for more than
a week. Triclosan became impregnated throughout the silicone catheter material and
completely inhibited the formation of crystalline biofilm, whereas catheters inflated with
water became blocked in 24 hr.64 A combination of Triclosan and DisersinB, a glycoside
hydrolase that disrupts biofilm, has shown synergistic antimicrobial and anti-biofilm
production activities against S. aureus, S. epidermidis and E. coli. 65 Similarly, a
combination of Triclosan and ethylenediaminetetraacetic acid in the urinary catheter has
proven to be effective in preventing E. coli colonization.66
Sutures:
Surgical site infections (SSIs) are the third most common nosocomial infections
and account for 14% to 16% of all such infections, and suture material may play a role in
the SSI rate. There are plenty of reports showing the usefulness of Triclosan-coated
suture in decreasing the risk for postoperative SSIs in a broad population of patients
undergoing surgeries of knee, hip, tibial plateau, and colorectal (Table 1).67-71 In addition
to these individual case studies, a meta-analysis using currently available data from many
databases suggests that Triclosan-coated sutures can significantly reduce the risk of SSIs
in both clean and contaminated surgery.72 However, the surface characteristics of suture
material may also be an important factor for the prevention of infection.73
Dental and implants:
A 2-year study shows that a Triclosan toothpaste (0.3%) was more efficient in
keeping a healthy period-implant environment than toothpaste without Triclosan.74 This
result is supported by other studies showing Triclosan toothpaste is more effective than
placebo toothpaste to control the periodontal condition in children whose parents are
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suffering from aggressive periodontitis.75 Dentifrice embeds with Triclosan also protect
erosion of the enamel.76 Triclosan-loaded chitosan particles can reduce the inflammatory
response in gingival fibroblasts and has been proposed to be an efficient periodontal
therapeutic agent.77 The Triclosan-containing fluoride toothpaste can modulate
inflammation in peri-implant mucositis.78, 79 For dental adhesive, Triclosan-loaded
chitosan could induce dentin/adhesive interface stability, which may improve the longlasting marginal sealing of the implant.80, 81
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Table 1. Summary of the applications of Triclosan in medical devices and sutures.
Application
Sample
Type of Surgery
Observation
(number)
Triclosan-coated sutures Dogs
Tibial plateau
Decreased Implantwith polydioxanone and (703)
leveling osteotomy Associated Infection
Triclosan-coated
(TPLO)
(IAI) rates after TPLO
poliglecaprone 25
Triclosan-impregnated
Humans
Gastrointestinal
Decreased incidence of
polydioxanone sutures
(183)
surgery
SSI (lower
gastrointestinal surgery)
Triclosan- coated
Humans
Total knee
Decreased inflammation
polyglactin sutures
(102)
arthroplasty (TKA) (IL-6) and no SSI
Triclosan-coated sutures systematic
Reduced the risk of SSIs
review of the
in both clean and
available
contaminated surgery.
literature
(11,957 )
Triclosan-coated sutures Humans
Coronary artery
Did not reduce the rate
(357)
bypass grafting
of sternal wound
infection
Triclosan-coated
polyglactin

Humans
(410)

Colorectal surgery

Triclosan-coated
polydioxanone suture

Humans
(150)

Emergent surgery

Reduced the incidence
of wound infections and
the costs in colorectal
surgery.
Reduced the incidence
of incisional SSI
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Year

Country

Reference

April 1, 2006
to December
31, 2014

United
States

67

October 2014
to March
2015
2011-2012

United
States

68

Taiwan

69

1946-2019

-

72

March 1,
2009 to
February 15,
2012.
2009-2011

Sweden

126

Japan

127

November
2018 and
March 2019.

Spain

128

Table 1 (continued). Summary of the applications of Triclosan in medical devices and sutures.
Application
Sample
Type of Surgery Observation
Year
(number)
Urinary catheter
Humans
Urinary
Triclosan had advantageous
November, 2016
impregnated with
(30)
safety profile
to February,
Triclosan,
2018
Triclosan containing Humans
Dental implant
Triclosan containing
June 2010 to
toothpaste
(102)
with peritoothpaste maintained a
December 2014
implantitis
healthy peri-implant
environment
Triclosan eluting
Humans
Stenting
Reduced several common
1-2 weeks
stent
(20)
ureteral-stent-related
symptoms

Country

Reference

United
Kingdom

62

Brazil

74

Canada
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Adverse effects of Triclosan:
Triclosan can enter the body with different routes. It can be absorbed through the skin and enter the bloodstream in test
animals.82 Triclosan in food and drink is rapidly absorbed and distributed in the human body.83 Inside the body, Triclosan can cross
the blood-brain barrier.84 Triclosan is metabolized by xenobiotic-metabolizing enzymes (XMEs) and excreted from the body rapidly
as conjugates primarily in urine within three hours after oral intake.83, 85, 86
Many diseases known to be related to Triclosan exposure are linked with modulation of the human enoyl-acyl carrier proteinreductase.87 Inside the cell, Triclosan may depolarize the plasma membrane at the neuromuscular junctions and induced mitochondrial
uncoupling leading to the distortion of Ca2+ homeostasis.88 Triclosan, among many other dietary compounds, can activate pregnane X
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receptor (PXR) -mediated transcription.89 The PXR receptor is expressed in the liver and
intestinal tissue to mediate the induction of enzymes involved in steroid metabolism and
xenobiotic detoxification. Also, Triclosan can increase cytosolic Ca2+ions, mitochondrial
radical oxidative species (ROS) production, and depolarized mitochondrial membrane
potential in cell cultures.90 Activation of the oxidative stress by Triclosan can affect cellcycle regulation and cell apoptosis.91, 92
Environment pollutants like phthalate, bisphenol A (BPA), triclocarban,
Triclosan, etc., are some of the major endocrine-disrupting chemicals.93-95 Women
exposed to Triclosan are more likely to develop osteoporosis, especially in
postmenopausal women.96 Triclosan, triclocarban, 2,2′,4,4′-tetrabromodiphenyl ether
(BDE-47), and BPA can disrupt thyroid hormone homeostasis by disrupting the
sodium/iodide symporter-mediated iodide uptake.97 Animal studies suggested the
exposure of pregnant mice to Triclosan would impair placental development and nutrient
transport;98 causes hyperphagic obesity of offspring via the hypermethylation of the
proopiomelanocortin promoter.99 In fetal female sheep, a low dose of Triclosan would
decrease the placental uptake and reduce estradiol sulfotransferase activity in the liver
and placenta.100 However, a low dose of Triclosan did not act as an endocrine disruptor in
the female rat reproductive system.101 Triclosan may affect the early development of
embryonic stem cell and zebrafish embryos by disturbing the expression of the
pluripotency markers Oct4, Sox2 and Nango.102
There are probably other binding targets for Triclosan in the human cells. A
docking-based computational analysis suggests that the human receptor-interacting
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protein-1 kinase, Apoptosis signal-regulating kinase-1, and B-cell lymphoma-2 of the
Apoptosis Signaling Pathway are good targets of Triclosan.87
Fetus and child development:
Using mixed linear models to estimate the associations between urinary chemical
levels and blood pressure of 644 pregnant women stratified by the fetus sexes, Liu and
associates found that Triclosan and selected benzophenones exposure might be associated
with blood pressure changes during pregnancy with a potential sex-different manner.103
During pregnancy, the maternal-fetal signaling is mediated in part by signaling molecules
such as microRNAs (miRNAs) contained in extracellular vesicles that are released by the
placenta into the maternal circulation. Exposure of a high level of Triclosan to women
has shown to downregulate the circulating placental derived extracellular vesicles
miRNA543.104 Exposure of Triclosan to the mothers can slightly influence the birth size
of the infant,105 leading to larger male offspring.105, 106 Wang and associates noticed that
the prenatal Triclosan exposure was related to increased cord testosterone levels,
decreased placental steroidogenic enzyme (3-beta-hydroxysteroid dehydrogenase, and
P450 aromatase) levels. Male infants tended to be more vulnerable to prenatal Triclosan
exposure.107 While Triclosan exposure is related to insulin resistance and metabolic
disorders in animals, Ouyang and associates suggest a potential risk for Triclosan
exposure of gestational diabetes mellitus (DM) in a gender-specific manner. But studies
from the National Health and Nutrition Examination Survey (NHANES 2013-2014),
suggested that triclocarban, not Triclosan exposure is positively associated with the risk
of Type 2 DM in women, but in men in the USA.8 Female infants born in regions with
widespread but moderate exposure of Triclosan show a higher birth weight than the male
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infants.108 On the other hand, in a prospective study, Guo and associates found that the
prenatal Triclosan exposure predicted increases in motor scores, while the postnatal
Triclosan exposure was related to reductions in social scores of 3-year-old boys.7
However, Wu and associates found no evidence for the prenatal Triclosan exposure
concerning fetal and early-childhood growth.109
The time of Triclosan exposure during pregnancy may influence child
development. Triclosan concentrations at delivery, but not during mid to late pregnancy
and childhood, were associated with significantly lower children’s cognitive test scores at
8 y of age in a cohort of U.S. children.110 However, Nakiwala and associates did not find
evidence of Triclosan in-utero exposure and the verbal and performance intelligence
quotient (IQ) among boys.111
Triclosan and Microbiota:
The health of the gut microbiota is an important factor for the overall health of the
individual.5, 112 Exposure to Triclosan can stimulate the gut microbiota causing colonic
inflammation and worsens the colitis-associated colon tumorigenesis.113-115 On the other
hand, Triclosan has been shown to enhance the clearing of pathogenic intracellular
Salmonella and Candida albicans in the gut.116
Triclosan and Cancer:
Triclosan has raised various health concerns as this compound has been reported
in various bodily secretions like human urines, breast milk, and plasma.83, 117 Cancer
cells often expressed a high level of lipid metabolism due to the demand of lipids for
membrane synthesis, energy storage, protein modification, and oncogenic signal
transduction.118 The primary target of Triclosan is fatty acid synthase. Many reports
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support the notion that Triclosan can be used to target fatty acid synthase and induce cell
death in cancer cells. However, some findings suggest that Triclosan can stimulate
growth on cancer cells through an ER-mediated signaling pathway or by inducing
Epithelial-to-Mesenchymal transition. Table 2 summarized some of the cancer promotion
and inhibition findings and their possible mechanisms. Overall, we concluded that more
research is needed to provide a more specific mechanism of action of Triclosan on cancer
development.
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Table 2. Summary of the various effects of Triclosan on cancer development and cancer
inhibition
Overall
Concentration Study
Mechanism(s)
Cells used
References
effect
of Triclosan
type
used in Study
Cancer
0.0001 μM In vitro Androgenic,
MCF7 human
130
inducing 10 μM
oestrogenic and breast cancer
Growth
cells and S115
stimulation
mouse
mammary tumor
cells
Cancer
0-10 μM
In vitro Epithelial-toAnoikis resistant 131
inducing
mesenchymal
Human Lung
transition
cancer cell NCIinduction,
H460
enhances cancer
cell survival,
enhances cancer
aggressiveness
Cancer
0.1–10 μM
In vitro Cell
VM7Luc4E2
132
inducing
proliferation and breast cancer
anti-apoptosis
cells
Cancer
0-20 μM
In vitro Induces
L02 Human
133
inducing
oxidative stress normal
in normal cell
hepatic cell line
and elevates
and HepG2
anti-oxidative
human
defense system
hepatocarcinoma
in cancer cells.
cell line
Cancer
1.73-27.68
In vivo altered gutC57BL/6 mice
115
inducing μM
microbiota,
Il-10−/− male
increased
mice
activation of
Tlr4−/− male
Toll-like
mice
receptor 4
(TLR4)
signaling
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Table 2 (continued). Summary of the various effects of Triclosan on cancer development
and cancer inhibition
Overall
Concentratio Study
Mechanism(s)
Cells used
Refere
effect
n of
type
nces
Triclosan
used in Study
Cancer
0.69 nm –
In vitro Estrogenic,
MCF‐7 BOS
134
inducing,
69.2 μM
Anti-estrogenic (in
human breast
Antipresence of 17‐
cancer cells
cancerous
β estradiol)
(17‐
β estradiol)
Anti0.1–10 μM
In vitro Anti-estrogenic,
MCF7 human
135
2+
cancerous
Stimulates Ca
breast cancer cells
mobilization.
Anti0-100 μM
In vitro Fatty acid synthase
MCF-7 and SK
136
cancerous
Inhibition (Human
Br-3 cells
and Goose),
Growth inhibition
Anti0-6.9 μM
In vitro Fatty acid synthase
Human
137
cancerous
and In
inhibition (Human)
retinoblastoma,
silico
Y79
Anti346 μM (in
In vivo Fatty acid synthase
Rat (Induced
138
cancerous
vivo)
and in
inhibition (Rat)
Mammary
0-250 μM (in vitro
carcinogenesis)
vitro)
Anti0-80 μM
In vitro Toxic to Prostate
LNCaP, C4-2B,
139
cancerous
cancer cells,
PC-3, 22RV1,
Inhibition of Fatty
RWPE-1,
acid synthase
LAPC4, BPH-1,
WPMY-1, and
3T3 cells

Conclusion and perspective:
Triclosan can affect humans both positively and negatively (Fig.3). As an
antimicrobial drug, the interactions are often determined by the type of organism, the
type of antibiotics, and other external factors. Thus, when applying Triclosan as a mixed
antimicrobial drug, practitioners need to consider these variables. Perhaps, a reference
database to systematically correlated Triclosan-antibiotics-bacteria interactions is needed.
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Experimental data on the interactions between Triclosan-microbiota in different
populations, genders, and ages are still missing. Also lacking are the data on the binding
sites of Triclosan to various human tissues. Machine learning models that can predict
potential toxic compounds, endocrine disruptors, and their interaction, especially with
Triclosan, can provide new insights to the benefit-risk analysis due to human exposure to
such compounds.119, 120 Additionally, greatly expanded bioinformatics-based
computational method 87 can be used to predict Triclosan-human interactions. For
example, the interactions between Triclosan and the drug-resistant efflux pumps of the
RND superfamily in bacteria are well published. One should be noted that the proteins of
the RND superfamily are common to all branches of life 36. Practically, all members of
the RND superfamily are involved in transporting substrates through the transmembrane
domain.35, 36, 121 In humans, the eukaryotic sterol transporter family and the patched
family are the best-characterized systems of the RND superfamily. The former family,
typified by the Niemann-Pick type C1 protein, is essential for the transport of externally
derived cholesterol from lysosomes to other organelles and keep homeostasis of sterol in
the body.122 The patched family mediates the efficient secretion of the cholesterolmodified ligand of the Hedgehog signaling pathway. The Hedgehog signaling pathway
plays critical roles in transmitting information to embryonic cells for proper cell
differentiation and in cancer.123 The hedgehog and other proteins in many aquatic
organisms are also sensitive to Triclosan.57 A computational approach to extract the
currently available data on the structural, functional, and mechanistic of the RND and
other superfamily proteins in bacteria and humans should reveal many more likely
Triclosan-binding sites in humans.
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Figure 3. Beneficial and harmful effects of Triclosan in Human health and bacteria.

Triclosan and related compounds have been shown to increases synthesis and
secretion of estrogen receptors in fish. 124 Since, these molecules can bind to the estrogen
receptors (ER), they are a potential endocrine disruptor in causing the reproductive,
neuroendocrine, and developmental disorders in humans as well as wildlife which is
discussed in detail elsewhere.125
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Chapter 4: Synergistic and antagonisitic interactions of triclosan with various
antibiotics in bacteria
Introduction:
Triclosan (TCS) is a non-ionic phenolic derivative. The compound has been used
as a broad-spectrum antimicrobial drug against many bacteria and fungi.1 TCS is found in
more than 2000 household and personal care products.2 Some, but not all products are
regulated by the Environmental Protection Administration (EPA) in the US. TCS at low
concentrations is a bacteriostatic agent. At high concentrations, TCS is a biocide. This
compound not only disrupts the membrane of the cell, but it also inhibits the synthesis of
fatty acids in bacteria, plants, and fungi.1 Several studies have now shown the association
of TCS with the emergence of multi-drug resistant ( MRS) bacteria. For example,
Escherichia coli and Pseudomonas aeruginosa become more resistant to
chloramphenicol and tetracycline following TCS exposure.3-6 Cross-resistance between
TCS and antibiotics have also been found in other bacteria.7 TCS is also known to induce
the multidrug efflux pump in many bacteria (for review, see ref 8). The widespread use
of TCS is, therefore, a major environmental health concern by stimulation of multidrug
resistance among bacteria.9, 10
Pathogens, such as P. aeruginosa, are listed by the World Health Organization as
leading MDR nosocomial bacteria.11 This organism is highly resistant to TCS and shows
MDR property. Stenotrophomonas maltophilia, another WHO-listed pathogen is a readily
emerging multidrug resistance pathogen with the potential of causing a pandemic.12-14
Although the effects and molecular mechanisms of TCS in individual bacteria have been
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well-documented, a systematic summary of the interactions between TCS-antibioticsbacteria has not been done.
In this study, we selected a wide range of bacteria from different genetically
distinct families and examined their responses to different classes of antibiotics with or
without the presence of TCS. We showed that TCS could act synergistically or
antagonistically with an antibiotic, depending on the type of bacteria and the class of
antibiotics. We also reported that the TCS-antibiotic antagonistic mechanism was closely
related to the activation of the multidrug efflux system in the bacteria.
Materials and Methods:
Triclosan-Antibiotic interaction assessment
Antibiotics tested and their mode of actions:
Six types of antibiotics targeting different parts of a bacterium were used in this
study. These included Ampicillin (a bacterial cell wall inhibitor), Erythromycin (a
bacteriostatic drug that binds to the 50S subunit of the rRNA complex); Kanamycin (a
drug that binds to the 30S rRNA, causing the misreading of tRNA); Norfloxacin (a
chemical that binds to the DNA gyrase); Tetracycline (a drug that prevents binding of
aminoacyl-tRNA to the RNA-ribosome complex); and Chloramphenicol (a drug that
interferes with ribosomal peptidyl transferase).
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Preparation of the antibiotic disk
Stock solutions of Triclosan (10 mg/ml), Chloramphenicol (50mg/ml) and
Erythromycin (50mg/ml) were prepared in 95% ethanol. Norfloxacin (20mg/ml) was
prepared in 0.1N HCl. Similarly, stock of Ampicillin (50mg/ml), Kanamycin (50mg/ml),
and Tetracycline (20mg/ml) were prepared in distilled water. Working solutions were
prepared from the stock in the respective solvents at a concentration of 1µg/µl. The final
amount of TCS used on the disks was 5µg and that of antibiotics was 10 µg.
Organisms used
Five Gram-positive bacteria belonging to the Bacilli Class, namely, Bacillus
subtilis 23857; Enterococcus faecalis 29212; Staphylococcus aureus BAA 976;
Staphylococcus saprophyticus BAA 750; and Staphylococcus epidermidis 12228 were
included in this study. Eleven species/strains of the Gram-negative bacteria were
selected. They included seven enterics – Escherichia coli (E. coli 12014, E. coli 35218
and E. coli K12); Proteus mirabilis 43071; Klebsiella (Enterobacter) aerogens 13048;
Enterobacter hormaechei 700323 and Klebsiella pneumonia BAA 1706; three members
of the Pseudomonadaceae Family —Pseudomonas aeruginosa 27853, Azotobacter
vinelandii OP, and Stenotrophomonas maltophilia 17666; and a common nosocomial
opportunist, Acinetobacter baumannii BBA-747 which belongs to the Moraxellaceae
Family.
TCS-antibiotic interaction procedure and calculation
Interactions of an antibiotic with or without TCS on a specific bacterial
species/strain were analyzed using the Kirby-Bauer (KB) method. Briefly, the bacteria
were spread on the Nutrient-agar (25 ml) plates. Air-dried disks with (A) the TCS alone,
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(B) antibiotic alone, and (C) antibiotic plus TCS, were placed on the inoculated agar
plates. The bacteria were incubated at 37 oC for 24-36 hours (Azotobacter vinelandii was
incubated at 30 oC). Disks containing the same amount of ethyl alcohol alone, after airdried, were included as a control. The amount of ethyl alcohol left in the air-dried disks
did not inhibit the bacterial growth in all test organisms. After incubation, the area of
inhibition (calculated as square millimeter) of (A), (B) and (C) was measured.
EtBr efflux extrusion kinetic assay
Some bacteria may resist TCS inhibition by inducing an efflux pump to remove
the TCS from the cells. Upon entering the cytoplasm, EtBr forms fluorescent complexes
with DNA. Many multidrug efflux systems can also use EtBr as substrate, resulting less
florescence of the cells. EtBr extrusion is an accepted method to demonstrate the
presence of multidrug efflux pumps in bacteria.15 Although the genome of
Stenotrophomonas maltophilia in GenBank (Locus NC_010943) suggested that this
organism has many genes related to the multidrug efflux system, experimental data of the
specificity of this efflux system is only emerging.12 We tested this organism for a TCSinducible multidrug efflux pump. S. maltophilia was grown in a defined media (M9
medium with 2% glucose) overnight and optical density (600 nm) of the culture was
adjusted to about 0.2 to 0.25 OD by diluting the overnight culture with the same media.
The diluted sample was separated into two sets. TCS was added to one set of the sample
to the final concentration of 200 ng/ml. Prior studies (data not shown) had shown that
TCS 200ng/ml did not inhibit the growth of S. maltophilia. The second set of samples
(control set) contained an equal volume of ethyl alcohol. An earlier study had shown at a
20-h incubation period with TCS was optimal for the EtBr efflux assay (data not shown).
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After incubation, the cells were washed three times with M9 medium (without glucose)
and resuspended in the same medium to 0.3 OD600 nm. An aliquot of 400 µl of the
washed-cells was transferred to a flat bottom 48-well Microtiter plate. EtBr, ranging from
253.6 μM to 0.4 μM (final concentration) was added to the wells. The fluorescence
intensity in each well was measured at every minute for up to 30 min. using a Bio-Tek
Synergy H1 Microplate Reader (BioTek, Vermont, USA) at the excitation wavelength
310 nm and an emission wavelength of 590 nm. EtBr enters the cell, and binds to DNA,
and fluoresces with higher intensity. Heat-killed cells were used to estimate the total
possible binding of EtBr to the cells. An efflux pump should extrude part of the EtBr
from binding to the DNA, leading to less fluorescence of the sample. EtBr extrusion was
measured as the decrease in fluorescence intensity in live cells as compared with the
fluorescence intensity in the heat-killed cells.
Heatmap Clustering
We wish to create an overview of the TCS-antibiotics-bacteria interactions of our
study. We normalized the area of inhibition to allow comparative analysis between
different antibiotics and different bacteria with or without TCS. Using Figure 1 as an
example, A, B, and C represent the inhibition zones of TCS alone, Antibiotic, and TCS
plus Antibiotic, respectively. We picked the largest zone of inhibition between (A) and
(B) (i.e. MAX (A, B)) and compared with the zone of inhibition of (C). The antibiotic
and TCS was considered as synergistic if the area of inhibition of (C) was larger than the
MAX (A, B); The antibiotic and TCS was considered to have no interaction if the area of
inhibition of (C) was equal to the MAX (A, B). The antibiotic and TCS were considered
as antagonistic if the area of inhibition of (C) was less than the MAX (A, B). Normalized

82

data (i.e. C/MAX (A, B)) was used to create the heatmap and cluster the bacteria using
the Reshape2 package from R (programming language- version 3.6.0).
EtBr staining in agar plates in Enterococcus faecalis
TCS showed two concentric inhibition zones (Inhibition-Zone-1 and InhibitionZone-2 labeled as Sections A and C, respectively, Figure 4) in Enterococcus faecalis. To
test the possibility of involvement of drug efflux, the plate was flooded evenly with 10 ml
of EtBr solution (2.5g/L). The excess liquid was drained out immediately. The plate was
let stand for 15 min until the media absorbed the EtBr solution. The EtBr fluorescence
was then observed with a BIO-RAD ChemiDoc (BioRAD, USA) under UV light. Thus,
the observed fluorescence image was converted to grayscale and assayed quantitatively to
find the difference in fluorescence at different regions of the plate using the “numpy”
library of Python (version 3.7). The relative cell density of these growth zones was
estimated at the wavelength of 600 nm before EtBr staining. The overall EtBr intensities
of the two growth zones were normalized by the cell densities. “Matplotlib” library of
Python was used to make the histogram.
Statistical analysis
All tests were done independently at least three times. In each experiment,
samples were done in triplicate. R software (The R Foundation for Statistical Computing,
Vienna, Austria), version 3.6.0 was used to make the graphs and perform statistical
analysis.16 Analysis of variance (ANOVA) test was used to test the significant difference
between the area of inhibition of antibiotics. A post hoc Tukey test was used for multiple
pairwise comparisons. Statistical significance was calculated at the 95% level of
significance (p<0.05). A p-value of less than 0.05 was flagged with one star (*); less than
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0.01was flagged with two stars (**) and less than 0.001 was flagged with three stars
(***).
Results:
We were interested to see if TCS would interfere with the action of antibiotics
against a specific type of bacteria. Our results show that TCS could often cross-interact
with certain antibiotics, resulting in either synergistic or antagonistic reactions, depending
on the type of antibiotics and the species of bacterium.
TCS-antibiotic interactions
A typical TCS-antibiotic synergistic interaction is illustrated in Figure 1, first row
(A.I, B.I, & C.I). TCS inhibits the growth of S. epidermidis, causing a ring of inhibition
zone of about 1353 sq. mm (Figure 1. A.I); The bacterium is also sensitive to
Erythromycin, forming a zone of inhibition of about 641 sq. mm, about 50% less than
that of the TCS (Figure 1. B.I); When the same amount of TCS and Erythromycin are put
into the disk, the area of inhibition was 1666 sq. mm (Figure 1. C.I); which is about 23%
larger than the area of inhibition of TCS alone.
A typical antagonistic reaction is demonstrated in the second row of (A.II, B.II, &
C.II) Figure 1. S. maltophilia is resistant to TCS, showing a very small inhibition zone
around the TCS-disk (Figure 1 A.II). S. maltophilia is sensitive to Norfloxacin, showing a
zone of inhibition of about 244 sq. mm (Figure 1 B.II). A 3-fold increase in Norfloxacinresistance is observed when TCS is included in the Norfloxacin disk (Figure 1. C.II).
Interestingly, E. faecalis formed two concentric inhibition zones around the TCS-disk
(Figure 1. A.III). Cells nearest to the TCS-disk are inhibited by TCS forming, an
inhibition zone (Inhibition-Zone-1) which is followed by a ring of growth (Growth-Zone1). As the concentration of TCS diffuses further outward, there is a second inhibition
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zone (Inhibition-Zone-2), before growth resumes forming an outer growth zone (GrowthZone-2).

Figure 1. Antibiotic sensitivity test in Staphylococcus epidermidis (AI, BI, CI),
Stenotrophomonas maltophilia (AII, BII, CII) and Enterococcus faecalis (AIII); AI, AII,
AIII- disk contains TCS alone; BI, BII- disk contains antibiotic alone; CI, CII) disk
contains antibiotic with TCS. N: Norfloxacin, E: Erythromycin, T: TCS. All antibiotics
used were 10µg/disk except TCS (5µg/disk).

Using the above-mentioned method, we tested 16 different species/strains of
bacteria of different phyla and families against 6 different antibiotics with or without the
presence of TCS. These results are summarized in Figure 2.
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Among the enterics (Figure 2a), almost all of them are resistant to Ampicillin and
Erythromycin; some of them are resistant to Kanamycin as well. All the enteric are very
sensitive to Norfloxacin among the antibiotics tested, except for K. pneumonia, which is
resistant to Norfloxacin. All of them are sensitive to TCS but the addition of TCS to the
antibiotics does not enhance or reduce the efficacy of these antibiotics. Our observations
are consistent with the results of Ledder et. al..17
Among the Bacilli (Figure 2b), B. subtilis, S. aureus, and S. epidermidis are
sensitive to many antibiotics and are highly sensitive to TCS. But E. faecalis and S.
saprophyticus are less sensitive to TCS. In B. subtilis, TCS shows significant
antagonistic interaction with all tested antibiotics. Significant antagonistic interaction of
TCS is also observed with Norfloxacin in S. aureus and with ampicillin in S.
saprophyticus. On the other hand, TCS can also enhance the efficacy of some antibiotics,
especially in some Bacilli. For example, TCS significantly improves the efficacies of
Ampicillin, Erythromycin, and Kanamycin against S. epidermidis.
For E. faecalis, sensitivity to TCS is bi-phasic (Figure 1, AIII) as mentioned
above. TCS also interacts synergistically with Chloramphenicol and Tetracycline, leading
to a 2-fold increase in the inhibition area against E. faecalis.
Among the Pseudomonadaceae (Figure 2C), the free-living soil bacterium A.
vinelandii is sensitive to TCS. TCS also does not interact with other antibiotics in this
organism. P. aeruginosa and S. maltophilia are phylogenetically related to A. vinelandii.
These bacteria are highly resistant to TCS and other antibiotics. The presence of TCS
also allows these bacteria to become more resistant to certain antibiotics. For example, in
P. aeruginosa, the presence of TCS decreases the area of the inhibition of Tetracycline by
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more than 3 folds. Similarly, in S. maltophilia, the presence of TCS reduces the area of
inhibition of Norfloxacin and Tetracycline by almost 3 and 2 folds, respectively (also see
Figure 1. B.II vs C.II).
Acinetobacter baumannii, a member of the Moraxellaceae Family, was sensitive to all
tested antibiotics. Like the enteric group, interference of TCS with the actions of all the
antibiotics tested in this bacterium was not significant (Figure 2d).
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Figure 2. Interaction between antibiotics and TCS in different bacteria. a) Gramnegative Enteric, b) Gram-positive Bacilli, c) Gram-negative Pseudomonadaceae and d)
Gram-negative Moraxellaceae. Kirby-Baur disk diffusion method was used to find the
zone of inhibition. Disks contained either antibiotic alone or TCS alone or antibiotic with
TCS. TCS was used at 5 µg/disk while other antibiotics were used at 10 µg/disk. R
programming language was used to test the significance of the difference between the
area of inhibition between the antibiotics at a 95% level of significance. Tukey post hoc
analysis was done for multiple pairwise comparisons. * Significant at the 5% level.
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Triclosan induces an efflux pump
The antagonistic effect of TCS toward certain antibiotics is interesting, especially
for those bacteria that are insensitive to TCS. EtBr is a common substrate for many
multidrug efflux systems, and the ability to remove EtBr is used as a biomarker of the
multidrug efflux system. 18 We assumed that TCS may induce a multidrug-resistant
pump, allowing the bacteria to remove the antibiotic from the cells. To test this
possibility, we tested the extrusion kinetic of EtBr in cells treated with TCS and
compared them with those untreated cells. We picked S. maltophilia because this
bacterium showed the most significant antagonistic effect against two different types of
antibiotics (Figure 1 CIII; Figure 2c).
S. maltophilia could extrude EtBr readily (as compared with heat-killed cells).
The EtBr extrusion curve followed typical Michaelis-Menten kinetics—showing the rate
of reduction in EtBr extrusion increased as a function of EtBr concentration until a
maximum concentration of EtBr (Vmax1) was reached. When cells were treated with
TCS overnight, cells exclude EtBr more readily, and the extrusion curve was biphasic—
at the lower concentrations of EtBr, the EtBr extrusion rates mimic that of the TCSuntreated cells. However, before the concentrations of EtBr reached a plateau of the
expected Vmax1, a new first order of EtBr extrusion kinetic was observed, leading to a
second maximum value (Vmax2). We used the Lineweaver-Burk plots to demonstrate
this phenomenon. Figure 3. shows that (Figure 3, blue solid line) the untreated cells
extrude EtBr readily, showing a Vmax and Km of 370 µM/min and 12.5 µM,
respectively. For the TCS-treated cells, we plotted the mixed order of EtBr extrusion
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kinetics separately. At lower EtBr concentrations, the TCS-treated cells show a Vmax
and Km of 588 µM/min and 16.67 µM respectively (Figure 3, dotted line). The kinetics
curve between the untreated cells and the TCS-treated cells at low EtBr concentrations
are almost parallel to each other. We should also mention that, because the transition
between the first and second extrusions was not obvious, determining data from the
“Lower EtBr concentrations” cut off points may be skewed. This may explain the
difference in Vmax and Km values between the two plots. However, when data on the
higher EtBr concentrations of the TCS-treated cells are plotted, it shows a much higher
Vmax (2,000 µM/min) and Km (200 µM /min). These data suggest that S. maltophilia
may have a basal ability to remove EtBr from the cell, and TCS could induce an extra
pump to remove EtBr more rapidly.

Figure 3. Lineweaver Burk plot for Stenotrophomonas maltophilia under TCS treated or
TCS untreated conditions. Plot for Treated cells exposed to high substrate concentration
and low substrate concentration were separated because of its bi-phasic nature. High
substrate (EtBr) concentration range was from 253.6 μM to 50.72 μM and a low
substrate concentration range was from 25.36 μM to 0.4 μM. EtBr extrusion was the
absolute value of the difference of the fluorescence of the live-cells from the heat-killed
cells.
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Concentration-dependent Triclosan resistance in Enterococcus faecalis
Two inhibition zones (Inhibition-Zone-1, and -2) and two growth zones (GrowthZone-1, and -2) were observed when E. faecalis was treated with TCS. This unique
inhibition of TCS against E. faecalis indicates that the resistance and sensitivity of this
bacteria to TCS seems to be TCS concentration-dependent. We speculated that E. faecalis
might be very sensitive to TCS. However, the sensitivity to TCS may be lessened by a
TCS-inducible multidrug-resistant system in this bacterium. We further speculated that
this TCS-inducible multidrug efflux system has a low affinity for TCS. Therefore, a
higher concentration of TCS is needed to induce this efflux system in this bacterium. To
test this possibility, we stained the bacteria on the agar plate with EtBr. If TCS at high
concentration could induce an efflux pump to partially counter the inhibitory effect of
TCS, those cells growing on Growth-Zone-1 should also be able to remove EtBr more
effectively. As a result, the fluorescence in Growth-Zone-1 should be less than the
fluorescence in Growth-Zone-2. This assumption proves to be the case. Figure 4. shows a
Histogram of fluorescence intensity (Darker lines) corresponding to the cell density
(Lighter lines) around the TCS-disk. The fluorescence intensity in both inhibition-zones 1
and 2 is very low (regions A and C). The fluorescence in Growth-Zone-1 (region B) is
more than 50% less than the fluorescence in those cells on the Growth-Zone-2 (region
D). It should be noted that the cell density on Growth-Zone-1 is thinner than the cell
density of Growth-Zone-2, suggesting TCS is partially inhibitory in Growth-Zone-1.
After normalizing for cell densities, the ratio of fluorescence per unit cell density in
Growth-Zone 1 is about 1.3; while the ratio of fluorescence per unit cell density in

91

Growth-Zone two is about 1.8. A reduction of about 30% of EtBr staining in GrowthZone-1 suggests that, despite the lower cell density, cells growing on Growth-Zone-1 are
more capable of removing EtBr than those cells growing on Growth-Zone-2.

Figure 4. Concentration Dependent Inhibition of Enterococcus faecalis by TCS. a) EtBr
fluorescence of the plate with bacterial growth under TCS treatment b) Histogram curve
of EtBr fluorescence intensity and bacterial density curve from the same plate (as in a).
Region A and C are two concentric zones of inhibitions, Region B is the inner ring of
bacterial growth, and Region D is the outer ring of bacterial growth. Fluorescence was
quantitatively assayed using the “numpy” library of Python.

Bacterial Phylogeny and TCS-drug interactions
Genetically related bacteria often share similar physiologic functions. Given the
complexity of TCS responses in different bacteria, we wish to see if the genetic
backgrounds of the bacteria are useful to predict the TCS-drug interactions. To test this
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possibility, we normalized the data from the TCS-antibiotics interaction data from Figure
2 and grouped the bacteria based on their synergism, neutralism (no interaction), or
antagonism responses to various antibiotics. As shown in Figure 5, the overall TCS-drug
interactions of bacteria seem to be genetically related. For example, the responses of most
of the Enterics, such as E. coli, Proteus, and K. aerogens to the TCS-antibiotics are
clustered to form a clade. The Bacilli, including S. aureus, S. saprophyticus, and B.
subtilis also share a similar TCS-antibiotic profile. Similarly, P. aeruginosa and S.
maltophilia are phylogenetically related and they are also grouped closely together.
However, there are also many exceptions, for example, the responses of A. vinelandii
(which is phylogenetically related to the Pseudomonas) and K. pneumonia (which is a
member of the Enterics), are more similar to those of the Bacilli cluster; whereas the
Enterococcus faecalis, a member of the Bacilli Class, shows a distinct TCS-Antibiotic
profile independent from other Bacilli. The grouping of bacteria based on their TCSantibiotics interaction profile does not correlate to the acceptable phylogenetic tree.19, 20
This suggests that some of these responses to TCS-antibiotics may be related to
horizontal gene transfers.8
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Figure 5. Summary heat map of antagonistic and synergistic interactions between TCS
and antibiotics. Normalized data of the area of inhibition was used to create the heat map
and clustering of bacteria. “reshape2” Package of R programming was used to create
the heatmap with the clustering. The Color intensity of 1 represents no interaction
between the respective antibiotic and TCS. Color intensity above or below 1 represents
Synergistic and Antagonistic interactions respectively.

Discussion:
Many researchers have reported TCS-antibiotics antagonistic effects in bacteria.21,
22

However, their focuses are often concentrated on one or a few bacterial species against

a particular antibiotic. A systematic study of TCS and its interactions with a broad range
of antibiotics in different groups of bacteria is lacking. We systematically analyzed the
interactions of different antibiotics with or without TCS in different bacterial phyla,
classes, and orders. We find that the interactions between TCS-antibiotics among
different bacteria are far more complex. TCS does not cross-interact with antibiotics in
many bacteria. However, TCS could enhance the efficacy of antibiotics in bacteria such
as E. faecalis and S. epidermidis. The synergistic effect of TCS and antibiotics should not
be surprising, because TCS inhibits the fatty acid synthesis and can induce oxidative
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stress to the bacteria.23 Stressed bacteria become more sensitive to other antibiotics. We
also observe an antagonistic effect of TCS with some antibiotics in other bacteria. The
antagonistic effects of TCS to antibiotics in B. subtilis, S. aureus, and S. saprophyticus
are likely due to the induction of a MDR efflux pump. MDR efflux pumps, such as the
qacA in S. aureus 24 and the bmr 25 in B. subtilis have been described in the literature.
Albeit, there are many types of MDR efflux pumps in these bacteria.6, 15, 26-28 Some of
these efflux pumps may be induced by TCS and may play a critical role in the
antagonistic interaction with other antibiotics. Earlier studies have shown that TCS could
induce an EfrAB efflux pump to remove TCS in E. faecalis.29 However, the authors did
not investigate the affinity of the TCS on the pump induction. In our study, we show that
the E. faecalis forms two zones of inhibition with two concentric rings of growth around
the TCS-disk (Figure 1). The more TCS-resistant cells growing on the Growth-Zone-1
also concomitantly extrude EtBr more efficiently than the cells growing on the GrowthZone-2 (Figure 4). It is known that TCS can inhibit fatty acid synthesis in bacteria.1 It is
also known that E. faecalis can activate the EfrAB efflux system 30 to resist TCS. Our
results thus suggest that at a very high concentration (Inhibition-Zone-1), E. faecalis
cannot grow due to fatty-acid synthesis inhibition. As TCS diffuse outward, the EfrAB
system in E. faecalis (as indicated by the stronger EtBr efflux Figure 4 region B) is
activated, allowing the bacteria to survive. The toxicity of TCS at Growth-Zone-1 may
still be significant. That could explain why the cell-density on Growth-Zone-1 is lower
than that on Growth-Zone-2 (Figure 4, region C). When TCS is further diffused outward,
the lower concentration of TCS may fail to active the efflux system, therefore, the E.
faecalis growth is inhibited, (Inhibition-Zone-2). To the best of our knowledge, we are
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the first to document and to analyze this concentric inhibition zones phenonium in the KB
test.
P. aeruginosa and S. maltophilia are resistant to TCS (Figure 2) because the FabV
protein of the lipid biosynthesis system of these bacteria is insensitive to TCS.31 These
organisms have the MexAB-OprM and MexCD-OprJ efflux system that can remove
various drugs.6, 32, 33 In P. aeruginosa, the MexAB-OprM efflux system is repressed by
the repressor Nalc. TCS binds to the Nalc protein, allowing the expression of the
MexAB-OprM efflux pump.33 TCS could probably induce additional drug efflux pumps
(such as the MexJK and the MexAB/XY ) 32, 34 in P. aeruginosa, allowing the cell to
resist tetracycline and other antibiotics (Figure 2c). The role of these pumps in the
survival of this bacterium remain unclear.
S. maltophilia is phylogenetically related to the Pseudomonas. The GenBank data
of S. maltophilia shows that the bacterium also carries a TCS-resistant fabV gene (locus
tag=" SMLT_RS09725", GenBank). This bacterium is known to exhibit the SmeYZ and
the SmeDEF as major efflux pumps. These efflux pumps are belonging to the resistancenodulation-division (RND) family drug efflux system 27. S. maltophilia may use the
SmeYZ efflux pump to remove EtBr (Figure 3). This could explain the basal low-Km;
low Vmax kinetics of the untreated cells. TCS can bind a repressor of the SmeDEF efflux
pump, the SmeT protein, in S. maltophilia.35 Removal of the repressor protein by TCS
could allow the SmeDEF efflux pump to become active. Conside ring this information
together, they could explain the bi-phasic enzyme kinetics of EtBr efflux in Figure 3. The
expression of MDR systems may allow the bacteria to become more resistant to
Tetracycline and Norfloxacin (Figures 1 & 2). However, S. maltophilia also contains

96

other multiple efflux pump genes, such as the MacB (locus-tag “SMLT_ RS12605”,
GenBank), the MexH (locus_tag="SMLT_RS09805"); the MATE
(locus_tag="SMLT_RS14155); and the DHA2 family (locus_tag="SMLT_RS17250").
Their participation in TCS-induced drug resistance cannot be ruled out.
Our study indicates that TCS interactions with drugs are strain-specific, however,
the efflux-pump and TCS resistant phenomena do not seem to match the known
phylogenetic organization of these bacteria (Figure 5). The possibility of Horizontal Gene
Transfer (HGT) of efflux-pump and TCS resistance in disrupting the phylogenetic
organization is likely. Some efflux pump genes are found to be plasmid-bound while
plasmid-encoded resistance genes are emerging as well.36 Also, it has been shown that
TCS itself can trigger ROS overproduction and induce HGT across different bacterial
genera. 4
Because of the common use of TCS in many commercial and medical products,37,
38

our current study suggests that broader testing for more bacteria and testing more

antibiotics are needed to understand the overall impact of TCS on disease treatment and
the environment.39, 40 Our results should remind clinical practitioners to consider the type
of infectious organisms, the types of antibiotics that are being treated in the presence of
TCS.
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Chapter 5: Conclusion.
Our understanding of how antibiotics ultimately kill the bacteria is still
incomplete. The sensitivity of bacteria to an antibiotic is directly influenced by many
environmental conditions. A detailed understanding of these environmental factors and
the interactions among these factors could give valuable insights towards improving the
efficacy of antibiotics.
We addressed the ongoing debates on whether ROS is or not a common pathway
for the antibiotic killing of bacteria (Keren et al., 2013; Kohanski et al., 2007; Liu &
Imlay, 2013). The common model organism, E. coli, used by other researchers for this
debate, has a major shortfall—this facultative anaerobe has multiple pathways (and thus
different mechanisms) to generate ROS. Thus, different growth conditions may result in
different ROS formation. The use of an obligate aerobic bacteria, Azotobacter vinelandii,
as the model organism can provide a clearer picture of the role of ROS leading to the
final death of bacteria. The proposed use of full factorial design allows one to examine
and select certain major factors that influence the sensitivity of an antibiotic. Our studies
concluded that only some bacteria are likely killed via the oxidative stress route.
Our study also raises an interesting question on the role of the environmental role
of xenobiotics, such as Triclosan (TCS), in affecting drug sensitivity. Aside from being
an antimicrobial agent itself, the xenobiotic seems to be able to induce drug resistance by
activating multidrug efflux pumps. Thus, depending on the type of antibiotics or the
strain of bacteria being tested, the presence of an exobiotic could act either synergistically
or antagonistically with some antibiotics.
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It has been known for some time that some strains of bacteria become resistant to
an antibiotic when the concentration of that antibiotic is higher than the MIC. Such effect,
called Paradoxical growth (or Eagle effect), is now partially clarified. Xenobiotics such
as TCS induces an efflux pump in some strains of bacteria only at high concentration.
The induction of the efflux pump in the bacterium coincides with TCS resistance.
Perhaps, the drug efflux pump gene expression in some bacteria requires a high dose of
inducers (i.e. the antibiotic). When the concentration of the inducer is below this critical
level, the bacterial growth is inhibited by the antibiotic. Once a critical concentration of
the antibiotic is reached, the efflux pump gene becomes expressed, allowing the bacteria
to grow. To our best knowledge, we are the first to associate paradoxical effect drug
efflux pump.
This study only could provide a general guide for antibiotic assay and efficacy
evaluation. Much more studies are needed to understand the triangulations between the
efficacies of various antibiotics, the environmental factors, the bacteria.
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Appendices
I: Supplementary figures for chapter 2
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g)
h)
Supp. Figure 1. Optimization of glucose and magnesium concentration. a) Contour
surface plot and b) Response surface plot for Erythromycin under different concentration
of magnesium and glucose. c) Contour surface plot and d) Response surface plot for
Erythromycin under different concentration of glucose and magnesium. e) Contour
surface plot and f) Response surface plot for Kanamycin under different concentration of
galactose and magnesium. g) Contour surface plot and d) Response surface plot for
Kanamycin under different concentration of Glucose and Magnesium
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a)

b)

c)

d)

e)

f)
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g)
h)
Supp. Figure 2. Optimization of carbon source and pH for maximizing the bacterial
sensitivity. a) Contour surface plot and b) RSM plot for erythromycin under different
concentration of galactose and pH. c) Contour surface plot and d) RSM plot for
erythromycin under different concentration of glucose and pH. e) Contour surface plot
and f) RSM plot for kanamycin under different concentration of galactose and pH. and g)
Contour surface pot and h) RSM plot for kanamycin under different concentration of
glucose and pH.

Supp. Figure 3. Pareto chart of final linear model for kanamycin treated cells at three
level of interaction.
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Supp. Figure 4. Pareto chart of final linear model for erythromycin treated cells with two
level interaction.
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Supp. Figure 5. Pareto chart of final linear model for erythromycin treated cells when a)
pH is 6 and carbon source is glucose, b) pH is 6 and carbon source is galactose, c) pH is
7 and carbon source is glucose, d) pH is 7 and carbon source is galactose.
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Supp. Figure 6. Pareto chart for final linear model for erythromycin treated cells with
three level interaction.
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II: Supplementary tables for chapter 2
Supp. Table 1. Full linear model summary statistics with two level of interaction for
kanamycin treated cells.
Std.
Significance
Coefficients:
Estimate
Error
t value Pr(>|t|)
(Intercept)
200.0339 19.5337 10.240 < 2e-16 ***
Sugar (Glucose)
36.3635 20.4022 1.782
0.07648 .
pH (7)
285.9199 20.4022 14.014 < 2e-16 ***
Ca (10mM)
27.246 20.4022 1.335
0.18352
Mg (10mM)
-0.1104 20.4022 -0.005 0.99569
KNO3 (40mM)
-27.1397 20.4022 -1.330 0.18522
Mannose (0.5%)
-33.8082 20.4022 -1.657 0.09935 .
Sugar (Glucose): pH (7)
-161.248 16.6584 -9.680 < 2e-16 ***
Sugar (Glucose): Ca (10)
-50.6284 16.6584 -3.039 0.00275 **
Sugar (Glucose): Mg (10)
25.0341 16.6584 1.503
0.13475
Sugar (Glucose): KNO3
(40mM)
26.6287 16.6584 1.599
0.11178
Sugar (Glucose): Mannose
(0.5%)
-10.8469 16.6584 -0.651 0.51584
pH (7): Ca (10mM)
-71.8071 16.6584 -4.311 2.75e-05 ***
pH (7): Mg (10mM)
25.3449 16.6584 1.521
0.13000
pH (7): KNO3 (40mM)
-10.2173 16.6584 -0.613 0.54047
pH (7): Mannose (0.5%)
-14.1341 16.6584 -0.848 0.39737
Ca (10mM): Mg (10mM)
30.4147 16.6584 1.826
0.06964 .
Ca (10mM): KNO3
(40mM)
49.6063 16.6584 2.978
0.00333 **
Ca (10mM): Mannose
(0.5%)
-6.6766 16.6584 -0.401 0.68907
Mg (10mM): KNO3
(40mM)
-74.8735 16.6584 -4.495 1.28e-05 ***
Mg (10mM): Mannose
(0.5%)
11.2394 16.6584 0.675
0.50078
KNO3 (40mM): Mannose
(0.5%)
35.6971 16.6584 2.143
0.03354 *
Significance codes: p-value: 0 – 0.001 = ‘***’, 0.001-0.01 = ‘**’, 0.01- 0.05 = ‘*’,
0.05-0.1= ‘.’
Residual standard error: 57.71 on 170 degrees of freedom
Multiple R-squared:0.7881, Adjusted R-squared: 0.762
F-statistic: 30.11 on 21 and 170 DF, p-value: < 2.2e-16
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Supp. Table 2. Final linear model summary statistics for kanamycin treated cells.
Std.
t
Significanc
Coefficients:
Estimate
Error
value
Pr(>|t|)
e
(Intercept)
207.693
17.03 12.196 < 2e-16
***
Sugar (Glucose)
30.94
18.472 1.675 0.095719 .
pH (7)
273.744
16.521 16.569 < 2e-16
***
Ca (10mM)
23.908
18.472 1.294 0.197267
Mg (10mM)
5.509
18.472 0.298
0.76586
KNO3 (40mM)
-32.248
18.472 -1.746 0.082594 .
Mannose (0.5%)
-44.017
11.682 -3.768 0.000225 ***
Sugar (Glucose): pH (7)
-161.248
16.521
-9.76 < 2e-16
***
Sugar (Glucose): Ca (10mM)
-50.628
16.521 -3.064 0.002527 **
Sugar (Glucose): Mg (10mM)
25.034
16.521 1.515 0.131514
Sugar (Glucose): KNO3 (40mM)
26.629
16.521 1.612 0.108816
pH (7): Ca(10mM)
-71.807
16.521 -4.346 2.34E-05 ***
pH (7): Mg (10mM)
25.345
16.521 1.534 0.126822
Ca (10mM): Mg (10mM)
30.415
16.521 1.841 0.067327 .
Ca (10mM): KNO3 (40mM)
49.606
16.521 3.003 0.003069 **
Mg (10mM): KNO3 (40mM)
-74.873
16.521 -4.532 1.08E-05 ***
KNO3 (40mM): Mannose
(0.5%)
35.697
16.521 2.161 0.032082 *
Significance codes: p-value: 0 – 0.001 = ‘***’, 0.001-0.01 = ‘**’, 0.01- 0.05 = ‘*’, 0.050.1= ‘.’
Residual standard error: 57.23 on 175 degrees of freedom
Multiple R-squared: 0.7855, Adjusted R-squared: 0.7659
F-statistic: 40.05 on 16 and 175 DF, p-value: < 2.2e-16
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Supp. Table 3. Full linear model for erythromycin treated cells with two level of
interaction.
Std.
Coefficients:
Estimate
Error
t value Pr(>|t|)
Significance
(Intercept)
536.072 22.582 23.739 < 2e-16
***
Sugar (Glucose)
150.328 23.586
6.374
7.01E-10 ***
pH (7)
192.761 23.586
8.173
8.71E-15 ***
Ca (10mM)
20.03 23.586
0.849
0.396431
Mg (10mM)
-98.678 23.586
-4.184
3.78E-05 ***
KNO3 (40mM)
34.356 23.586
1.457
0.146269
Mannose (0.5%)
6.232 23.586
0.264
0.791801
Sugar (Glucose): pH (7)
-307.584 19.258 -15.972 < 2e-16
***
Sugar (Glucose): Ca
(10mM)
71.582 19.258
3.717
0.000241 ***
Sugar (Glucose): Mg
(10mM)
116.114 19.258
6.029
4.86E-09 ***
Sugar (Glucose): KNO3
(40mM)
-62.245 19.258
-3.232
0.001366 **
Sugar (Glucose):
Mannose (40mM)
9.093 19.258
0.472
0.637135
pH (7): Ca (10mM)
-69.422 19.258
-3.605
0.000366 ***
pH (7): Mg (10mM)
14.429 19.258
0.749
0.454289
pH (7): KNO3 (40mM)
-8.931 19.258
-0.464
0.643143
pH (7): Mannose (0.5%)
-4.214 19.258
-0.219
0.826934
Ca (10mM): Mg
(10mM)
17.163 19.258
0.891
0.373519
Ca (10mM): KNO3
(40mM)
-15.74 19.258
-0.817
0.414398
Ca (10mM): Mannose
(0.5%)
-44.323 19.258
-2.302
0.022049 *
Mg (10mM): KNO3
(40mM)
-4.666 19.258
-0.242
0.808732
Mg Ca (10mM):
Mannose (0.5%)
-9.118 19.258
-0.473
0.636226
KNO3 (40mM):
Mannose (0.5%)
34.202 19.258
1.776
0.076756 .
Significance codes: p-value: 0 – 0.001 = ‘***’, 0.001-0.01 = ‘**’, 0.01- 0.05 = ‘*’,
0.05-0.1= ‘.’
Residual standard error: 86.12 on 298 degrees of freedom
Multiple R-squared: 0.5702, Adjusted R-squared: 0.5399
F-statistic: 18.83 on 21 and 298 DF, p-value: < 2.2e-16
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Supp. Table 4. Final linear model for erythromycin treated cells with two level of
interaction.
Std.
t
Significan
Coefficients:
Estimate
Error
value
Pr(>|t|)
ce
(Intercept)
536.568
17.86 30.043 < 2e-16
***
Sugar (Glucose)
154.874
21.347
7.255
3.32E-12 ***
pH (7)
193.403
16.535 11.696 < 2e-16
***
Ca (10mM)
20.742
19.093
1.086
2.78E-01
Mg (10mM)
-89.773
13.501 -6.649
1.35E-10 ***
KNO3 (40mM)
19.688
16.535
1.191 0.234715
Mannose (0.5%)
4.112
16.535
0.249 0.803761
Sugar (Glucose): pH (7)
-307.584
19.093 -16.11 < 2e-16
***
Sugar (Glucose): Ca10
71.582
19.093
3.749 0.000212 ***
Sugar (Glucose): Mg10
116.114
19.093
6.081
3.55E-09 ***
Sugar (Glucose): KNO3
(40mM)
-62.245
19.093
-3.26 0.001239 **
pH (7): Ca (10mM)
-69.422
19.093 -3.636 0.000325 ***
Ca (10mM): Mannose
(0.5%)
-44.323
19.093 -2.321 0.020921 *
KNO3 (40mM): Mannose
(0.5%)
34.202
19.093
1.791 0.074235 .
Significance codes: p-value: 0 – 0.001 = ‘***’, 0.001-0.01 = ‘**’, 0.01- 0.05 = ‘*’,
0.05-0.1= ‘.’
Residual standard error: 85.39 on 306 degrees of freedom
Multiple R-squared: 0.5662, Adjusted R-squared: 0.5477
F-statistic: 30.72 on 13 and 306 DF, p-value: < 2.2e-16
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